WORK for the past five decades on the yeast *Saccharomyces cerevisiae* has contributed fundamental insight into peroxisome biogenesis and function that is also relevant for mammalian cells. While LD research in yeast is still in its infancy and looks back to a much shorter history---the previous edition of *YeastBook* did not even mention LDs as an "organelle"---combined biochemical, cell biological, lipidomic, and proteomic studies in recent years have already contributed significant insight into LD biogenesis and function.

Lipid Droplets {#s1}
==============

LDs, also termed "lipid particles," "lipid bodies," or "oil bodies," are ubiquitous subcellular structures that have only in recent years been recognized as metabolically highly dynamic organelles ([@bib64]; [@bib95]; [@bib109], [@bib110]; [@bib119]; [@bib178]; [@bib226]; [@bib241]; [@bib349], [@bib350]; [@bib21]). In the past, LDs were primarily considered as rather inert storage depots for the '"neutral lipids," triacylglycerols (TAG) and steryl esters (SE). However, the increased biomedical interest in understanding neutral lipid homeostasis, fueled by the pandemic increase in lipid-associated disorders, has moved LDs into the spotlight of biomedical research ([@bib87]; [@bib350]). Given the significant homology of lipid biosynthetic processes to mammalian cells, yeast LD research has gained a great momentum to address the fundamental mechanisms of LD assembly and the regulation of neutral lipid homeostasis ([@bib20], [@bib21]; [@bib62]; [@bib64],[@bib65]; [@bib267]; [@bib172],[@bib173]).

Among subcellular organelles, LDs are unique in their structure, as they appear to harbor only a monolayer of phospholipids that surrounds the hydrophobic core consisting of TAG and SE. A second feature standing out is that LDs, like peroxisomes, are organelles that are not essential under standard nutritional conditions, *i.e.*, in the presence of carbon sources other than fatty acids (FA). Unlike other organelles, LD biogenesis and degradation need to be discussed in the context of the synthesis and turnover of their major components, namely neutral lipids: their biogenesis is driven by the availability of precursors for the synthesis of their core compounds, TAG and SE, and cells are devoid of LDs in the absence of the cellular capacity to synthesize these lipids ([@bib97]; [@bib258]). On the other hand, TAG synthesis---and concomitant formation of LDs---is essential for cell survival in the presence of excess FAs ([@bib97]; [@bib258]; [@bib86]). The LD surface is decorated with numerous proteins that are, in part, also present in the endoplasmic reticulum (ER) membrane, raising the question as to the specific signals that target proteins to the LD surface. The highly dynamic nature of LDs in growing cells reflects the importance of neutral lipids in various stages of cell growth and in response to the nutritional status of the cell; the metabolic role of LDs is highlighted by the recent discoveries that TAG-derived metabolites are required for efficient cell cycle progression ([@bib184]) and that TAG play an essential role in counteracting FA-induced lipotoxicity ([@bib97]; [@bib258]; [@bib86]).

Experimental approaches to studying LD biology {#s2}
----------------------------------------------

*In vivo*, LDs are readily detectable by transmission light microscopy (differential interference contrast (DIC; Nomarski optics) due to their high refractive index ([Figure 1](#fig1){ref-type="fig"}). Numerous cell-permeable hydrophobic fluorescence dyes that label LDs with high specificity, including Nile Red, LD540, and BODIPY dyes, exist ([@bib317]; [@bib89]; [@bib360]; [@bib306]; [@bib363], [@bib364]). It should be noted, however, that these dyes are potential substrates of the pleiotropic drug resistance pumps ([@bib147]), and staining efficiency may strongly depend on the activity of these pumps in the respective strain backgrounds. Thus, staining of LDs in growing cultures that contain both young and aged cells may appear quite heterogeneous; fixation of cells with formaldehyde or elimination of Pdr pumps strongly increases labeling efficiency ([@bib360]; [@bib361], [@bib364]). Given the specificity and ease of labeling of both living and fixed cells, several microscopy- or photometry-based screens of yeast mutant collections have been performed to identify mutants with altered LD morphology and content ([@bib317]; [@bib89]; [@bib37]; [@bib2]; [@bib88]). In addition, green fluorescent protein-tagged reporter constructs of LD-associated proteins provide an additional tool for studying LD dynamics and inheritance ([@bib183]; [@bib148]; [@bib364]). It should be noted that the number and size of LDs vary greatly between various yeast wild-type strains, and it is currently unclear which genetic traits are responsible for this heterogeneity. Microscopy-based screens of the GFP-labeled protein collection ([@bib145]) have also led to the identification of numerous novel LD-associated proteins ([@bib229]; see below). In addition to the use of hydrophobic fluorescent dyes, recent advances in spectroscopic imaging techniques such as coherent anti-Stokes Raman scattering (CARS) microscopy allow the label-free imaging of yeast LDs ([@bib38]; [@bib173]; [@bib364]). This technology is based on the C-H molecular vibrations in the FA acyl chains that are packed in high density as TAG in the LD, and thus independent of exogenously supplied fluorescent dyes or endogenously expressed fluorescent protein reporter constructs (see also [Figure 1](#fig1){ref-type="fig"}).

![Morphological characteristics of yeast lipid droplets. (Rows 1--3, left panels) Fluorescence images of LDs that are labeled with BODIPY 493/503 ([@bib360]; [@bib361], [@bib364]). (Right panels) Corresponding transmission images. All strains, except the *fld1*Δ mutant, were cultivated for 72 h in YPD complete medium; *fld1*Δ mutants were grown in synthetic complete (minimal) medium with 2mg/liter inositol for 12 h. Images were obtained by confocal laser scanning microscopy and represent projections of 8--12 optical sections. wt, wild type; *tgl3*Δ *tgl4*Δ, mutant lacking the major TAG lipases; *are1*Δ *are2*Δ, mutant lacking the steryl ester synthases and thus harboring LDs that contain TAG only; *dga1*Δ *lro1*Δ, mutant lacking acyl-CoA and phospholipid-dependent diacylglycerol (DAG) acyltransferases and thus harboring LDs that contain SE only; *fld1*Δ mutant, lacking the yeast ortholog of seipin. TEM: transmission electron microscopy images of wild type (wt) and the *fld1*Δ mutant. (Row 4) Electron tomography (ET) of LDs in wild type, showing close association of LDs with the ER membrane. CARS: coherent anti-Stokes Raman scattering microscopy of LDs in wild type, *tgl3*Δ *tgl4*Δ mutant, and *dga1*Δ *lro1*Δ mutant. CARS is a label-free imaging technique that generates contrast by imaging molecular vibrations at 2840 cm^−1^. Scale bar: 500 nm in the TEM images, 200 nm in the ET image, and 5 μm in the fluorescence/transmission images. See text for details. Images courtesy of H. Wolinski (fluorescence and CARS microscopy) and D. Kolb (electron microscopy and tomography).](1fig1){#fig1}

Higher resolution images of LDs are obtained by electron microscopy and electron tomography ([@bib30]; [@bib255]; [@bib63]; [@bib148]; [@bib363]) ([Figure 1](#fig1){ref-type="fig"}), which also demonstrate their close physical interactions with other intracellular organelles, in particular the ER, mitochondria, and peroxisomes ([@bib30]; [@bib264]). Biophysical studies on isolated LDs have been performed using X-ray small-angle scattering analyses, dynamic light scattering, and differential scanning calorimetry to unveil LD size distribution and structural organization, depending on lipid composition ([@bib63]; [@bib308]; see below).

LD can be purified from cellular extracts by ultracentrifugation/flotation ([@bib194]; [@bib22]; [@bib59]). Since LDs are in close contact with other intracellular organelles, a clean LD preparation requires careful cell lysis (*e.g.*, enzymatic digestion of the cell wall with Zymolyase), followed by differential centrifugation, to obtain a layer of LDs---together with vacuolar membranes---floating on top of the centrifuge tube. Attached vacuolar membranes are separated by an additional centrifugation step that requires a pH/buffer change ([@bib22]; [@bib59]; [@bib114]). This protocol restricts LD preparations to cells in late log/early stationary phase that are susceptible to Zymolyase lysis of the cell wall.

Lipid droplet structure {#s3}
-----------------------

LDs isolated from yeast are rather homogeneous in size, ranging from typically 300 nm (in late log phase) to 1 μm (in stationary phase) in diameter. In the late log/early stationary phase of growth, the majority of LDs fall into a rather narrow 350- to 450-nm size range, largely independent of their lipid composition ([@bib63]). As discussed below, LDs are subject to high metabolic turnover and may be almost completely degraded during the early log phase of growth ([@bib183]). Wild-type LDs containing about equal amounts of TAG and SE are typically spherical structures, in which the core of neutral lipids is surrounded by a monolayer of phospholipids, which, according to the current biogenesis models, is derived from the ER membrane (*Mechanisms of LD biogenesis and inheritance*). X-ray small-angle scattering experiments have unveiled some level of supramolecular organization of LDs, indicating that SE form a shell surrounding the rather fluid disordered TAG core ([@bib63]). A *[hem1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002640)* mutant that is defective in sterol synthesis accumulates the sterol intermediate squalene in LDs, which is found in subcellular membranes as well as in LD and leads to a disordering of the shell structure ([@bib308]).

Lipid composition of purified LDs {#s4}
---------------------------------

The major lipid components of LDs are the neutral lipids, TAG and SE ([@bib381]; [@bib194]; [@bib59]). In mammalian cells, LD composition may vary, depending on cell type, and contain mostly TAG (as in adipocytes) or TAG and cholesteryl esters, retinylesters, and free cholesterol (as in liver). It should be emphasized that the designation "neutral lipid' of these compounds refers to their uncharged and highly hydrophobic structure, but not to their (active) involvement in cellular metabolism. TAG and SE are present in about equal amounts in LDs ([@bib65]; [@bib63]; [@bib267]; [@bib59]; [@bib114]). The TAG molecular species distribution reflects the cellular content of long-chain FAs, namely predominantly C16 and C18 saturated and mono-unsaturated FAs, giving rise to the most prominent 48:2, 50:2, 50:3, 52:2, and 52:3 TAG molecular species[^1^](#fn1){ref-type="fn"} in wild-type cells grown on glucose ([@bib59]; [@bib114]). Somewhat different TAG profiles were obtained for cells grown on raffinose ([@bib77]). This finding also reflects the dynamic nature of LDs \[and the entire yeast lipidome for that matter ([@bib167])\] that respond quickly to growth rate and carbon source. Accordingly, growth of yeast in the presence of oleic acid as the sole carbon source results in TAG species predominantly composed of TAG 54:3 ([@bib114]). The SE fraction is mainly composed of ergosterol esterified with oleic acid (C18:1) and palmitoleic acid ([@bib63]), but sterol intermediates, such as zymosterol, episterol, and fecosterol are also found esterified in the SE fraction ([@bib386]; [@bib63]).

The phospholipid monolayer of LDs is enriched in the anionic phospholipid, phosphatidylinositol, compared to total cellular phospholipids ([@bib293]; [@bib59]; [@bib114]); notably, the molecular species distribution of LD phospholipids is quite distinct from that of the ER membrane, from which it is presumably derived ([@bib59]; [@bib114]), and appears to be enriched in double-unsaturated species ([@bib293]). Notably, phosphatidylinositol molecular species with medium-chain fatty acids (C12 and C14), which are quite prominent in subcellular membranes ([@bib77]; [@bib167]), are excluded from the LD phospholipid monolayer ([@bib293]).

Protein composition of LDs {#s5}
--------------------------

Although LDs are present in almost all cell types, ranging from bacteria to mammals, their protein composition is rather divergent ([@bib225]; [@bib368]). The proteome of highly purified LDs from yeast is composed of a characteristic set of proteins, but the overall protein content is rather low ([Table 1](#t1){ref-type="table"}). Notably, most of the LD-resident enzymes identified so far play a role in lipid metabolism, emphasizing the active role of this organelle in cellular metabolism ([@bib20]; [@bib62]; [@bib64],[@bib65]; [@bib267]; [@bib173]; [@bib114]). Notably, the set of LD-associated proteins may substantially change during cellular growth, in particular if FAs such as oleic acid are supplied, to induce formation of LDs and peroxisomes ([@bib114]). Also, size and phospholipid composition that are dependent on growth conditions and media composition (*e.g.*, presence or absence of the phospholipid precursor inositol) may influence the LD proteome ([@bib92]). Numerous LD-associated proteins display a dual localization also to the ER ([Table 1](#t1){ref-type="table"}; see below), and their relative distribution to both organelles may change during various stages of growth. Since LDs closely interact with other subcellular organelles, some of the identified proteins may actually be contaminants during preparation. On the other hand, a transient association of non-LD-resident proteins may also be of physiological significance (see *Physiological role of LDs*): evidence suggests that association of proteins with LDs, at least in mammalian cells, may serve a protective or regulatory role ([@bib137]).

###### Neutral lipid metabolism enzymes and LD-associated proteins

  Gene                                                                       Enzyme                                                                              Molecular mass (kDa)   Isoelectric point   Molecules per cell[*^a^*](#t1n1){ref-type="table-fn"}   Location[*^b^*](#t1n2){ref-type="table-fn"}             Transmembrane domains   Phosphorylation sites[*^c^*](#t1n3){ref-type="table-fn"}
  -------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------- ------------------- ------------------------------------------------------- ------------------------------------------------------- ----------------------- ----------------------------------------------------------
  **Neutral lipid synthesis enzymes**                                                                                                                                                                                                                                                                                                               
  *SCT1 (GAT2)*                                                              Glycerol-3-P/dihydroxyacetone-P acyltransferase                                     85.7                   7.27                1,050                                                   ER                                                      4                       Few
  *GPT2 (GAT1)*                                                              Glycerol-3-P/dihydroxyacetone-P acyltransferase                                     83.6                   10.3                3,100                                                   ER, lipid droplets                                      4                       Several
  *AYR1*                                                                     Acyl DHAP reductase                                                                 32.8                   9.92                3,670                                                   ER, lipid droplets                                      None                    None
  *SLC1*                                                                     LysoPA/Acylglycerol-3-P acyltransferase                                             33.8                   10.41               ND[*^d^*](#t1n4){ref-type="table-fn"}                   ER, lipid droplets                                      1                       None
  *ALE1 (SLC4*, *LPT1*, *LCA1)*                                              LysoPA/Acylglycerol-3-P acyltransferase                                             72.2                   10.3                ND                                                      ER                                                      7                       Several
  *PHM8*                                                                     LysoPA phosphatase                                                                  37.7                   5.14                195                                                     Cytoplasm, nucleus                                      None                    None
  *LOA1 (VPS66)*                                                             LysoPA acyltransferase                                                              33.8                   10.5                6,630                                                   ER, lipid droplets                                      1                       None
  *PAH1* (*SMP2*)                                                            PA phosphatase                                                                      95                     4.68                3,910                                                   Cytoplasm, ER                                           None                    Several
  *DGK1* (*HSD1*)                                                            DAG kinase                                                                          32.8                   9.48                784                                                     ER                                                      4                       Few
  *DGA1*                                                                     Acyl-CoA diacylglycerol acyltransferase                                             47.7                   10.39               907                                                     ER, lipid droplets                                      1                       Few
  *LRO1*                                                                     Phospholipid diacylglycerol acyltransferase                                         75.3                   6.67                ND                                                      ER                                                      1                       Few
  *ARE1* (*SAT2*)                                                            Acyl-CoA sterol acyltransferase                                                     71.6                   8.27                ND                                                      ER                                                      9                       Several
  *ARE2* (*SAT1*)                                                            Acyl-CoA sterol acyltransferase                                                     74.0                   7.71                279                                                     ER                                                      9                       Several
  **Neutral lipid turnover enzymes**                                                                                                                                                                                                                                                                                                                
  *LDH1*                                                                     Triacylglycerol lipase, hydrolase                                                   43.3                   6.51                ND                                                      Lipid droplets                                          None                    None
  *TGL1 (YKL5)*                                                              Triacylglycerol lipase, sterylester hydrolase                                       63.0                   6.83                1,470                                                   ER, lipid droplets                                      1                       Several
  *TGL2*                                                                     Acylglycerol lipase                                                                 37.5                   8.41                ND                                                      Mitochondria                                            None                    None
  *TGL3*                                                                     Triacylglycerol lipase, lysoPA acyltransferase                                      73.6                   8.50                3,210                                                   Lipid droplets                                          1                       Few
  *TGL4 (STC1)*                                                              Triacylglycerol lipase, Ca^++^ dependent phospholipase A2, lysoPA acyltransferase   102.7                  8.05                195                                                     Lipid droplets                                          None                    Several
  *TGL5 (STC2)*                                                              Triacylglycerol lipase, lysoPA acyltransferase                                      84.7                   9.84                358                                                     Lipid droplets                                          1                       Several
  *YEH1*                                                                     Sterylester hydrolase                                                               66.5                   6.33                7,770                                                   Lipid droplets                                          1-2                     None
  *YEH2*                                                                     Sterylester hydrolase                                                               62.4                   8.91                1,630                                                   Plasma membrane                                         1                       Few
  *YJU3*                                                                     Monoacylglycerol lipase                                                             35.6                   8.5                 2,140                                                   Lipid droplets, ER                                      None                    None
  **Lipid droplet-associated proteins**[*^d^*](#t1n4){ref-type="table-fn"}                                                                                                                                                                                                                                                                          
  *ATF1*                                                                     Alcohol-*O*-acetyltransferase                                                       61.0                   6.94                1,990                                                   Lipid droplets                                          None                    None
  *AYR1*                                                                     Acyl DHAP reductase                                                                 32.8                   9.92                3,670                                                   ER, lipid droplets                                      None                    None
  *BSC2*                                                                     Unknown function                                                                    26.6                   5.10                922                                                     Lipid droplets                                          1                       None
  *COY1*                                                                     Unknown function, similarity to mammalian CASP                                      77.5                   5.93                2,650                                                   Lipid droplets, Golgi                                   1                       Several
  *CPR5 (CYP5)*                                                              Peptidyl-prolyl *cis*-*trans* isomerase (cyclophilin)                               25.3                   5.40                ND                                                      Lipid droplets, ER                                      1                       1
  *CSR1 (SFH2)*                                                              Phosphatidylinositol transfer protein                                               47.5                   6.61                9,600                                                   Lipid droplets, cytoplasm                               None                    1
  *CST26 (PSI1)*                                                             Stearoyl-CoA acyltransferase, phosphatidylinositol-specific                         45.5                   10.15               2,010                                                   Lipid droplets, ER                                      Four                    None
  *EHT1*                                                                     Acyl-coenzymeA ethanol *O*-acyltransferase                                          51.3                   7.83                2,550                                                   Lipid droplets, ER                                      None                    None
  *ENV9*                                                                     Unknown function, similarity to oxidoreductases                                     37.5                   8.35                967                                                     Lipid droplets                                          1                       None
  *ERG1*                                                                     Squalene epoxidase                                                                  55.1                   6.45                65,400                                                  Lipid droplets, ER                                      2                       None
  *ERG27*                                                                    3-Keto sterol reductase                                                             39.7                   8.90                ND                                                      Lipid droplets                                          None                    1
  *ERG6 (ISE1*, *LIS1*, *SED6*, *VID1)*                                      Δ^24^-Sterol *C*-methyltransferase                                                  43.3                   5.60                53,800                                                  Lipid droplets, ER                                      None                    Few
  *ERG7*                                                                     Lanosterol synthase                                                                 83.5                   6.59                2,190                                                   Lipid droplets, ER                                      None                    None
  *FAA1*                                                                     Fatty acyl-CoA synthetase                                                           77.8                   7.58                7,470                                                   Lipid droplets, ER                                      None                    None
  *FAA4*                                                                     Fatty acyl-CoA synthetase                                                           77.2                   6.52                31,200                                                  Lipid droplets, ER                                      None                    None
  *FAT1*                                                                     Fatty acid transporter and fatty acyl-CoA synthetase                                77.1                   8.47                16,900                                                  Lipid droplets, ER                                      3                       None
  *GTT1*                                                                     Glutathione *S*-transferase                                                         26.8                   6.65                ND                                                      Lipid droplets, ER                                      None                    None
  *HFD1*                                                                     Hexadecenal dehydrogenase                                                           60.0                   6.73                2,930                                                   Lipid droplets, mitochondria                            1                       1
  *KES1 (LPI3*, *OSH4*, *BSR3)*                                              Member of the oxysterol binding protein family                                      49.5                   5.92                32,200                                                  Lipid droplets, cytoplasm                               None                    None
  *LDB16*                                                                    Unknown function                                                                    29.0                   8.07                149                                                     Lipid droplets                                          2                       1
  *LOA1 (VPS66)*                                                             LysoPA acyltransferase                                                              33.8                   10.5                6,630                                                   Lipid droplets, ER                                      1                       None
  *NUS1*                                                                     Putative prenyltransferase                                                          42.6                   6.94                ND                                                      Lipid droplets, ER[*^e^*](#t1n5){ref-type="table-fn"}   1                       None
  *OSW5*                                                                     Unknown function                                                                    16.4                   9.94                922                                                     Lipid droplets                                          2                       1
  *PDI1 (MFP1*, *TRG1)*                                                      Protein disulfide isomerase                                                         58.2                   4.22                ND                                                      Lipid droplets, ER (lumen)                              None                    None
  *PDR16 (SFH3)*                                                             Phosphatidylinositol transfer protein                                               40.7                   8.16                15,400                                                  Lipid droplets, cytoplasm                               None                    2
  *PET10*                                                                    Unknown function                                                                    31.2                   8.85                2,160                                                   Lipid droplets                                          None                    None
  *RRT8*                                                                     Unknown function                                                                    39.6                   10.66               ND                                                      Lipid droplets                                          5                       None
  *SLC1*                                                                     LysoPA/Acylglycerol-3-P acyltransferase                                             33.8                   10.41               ND                                                      Lipid droplets, ER                                      1                       None
  *SNA2*                                                                     Unknown function                                                                    9.2                    6.50                20,400                                                  Lipid droplets                                          2                       1
  *SNX41*                                                                    Sorting nexin                                                                       70.7                   7.02                1,800                                                   Lipid droplets, cytoplasm                               None                    None
  *SRT1*                                                                     *Cis*-prenyl transferase                                                            40.2                   10.30               ND                                                      Lipid droplets                                          1                       None
  *SSO1*                                                                     t-SNARE                                                                             33.1                   5.06                450                                                     Lipid droplets, vesicles                                1                       1
  *TDH1 (GLD3)*                                                              Glyceraldehyde-3-phosphate dehydrogenase, isozyme 1                                 35.8                   8.59                120,000                                                 Lipid droplets, cytoplasm                               None                    Several
  *TDH2 (GLD2)*                                                              Glyceraldehyde-3-phosphate dehydrogenase, isozyme 2                                 35.8                   6.96                121,000                                                 Lipid droplets, cytoplasm                               None                    Several
  *TDH3 (GLD1*, *HSP35*, *HSP36*, *SSS2)*                                    Glyceraldehyde-3-phosphate dehydrogenase, isozyme 3                                 35.7                   6.96                169,000                                                 Lipid droplets, nucleus, cytoplasm                      None                    Several
  *TGL1 (YKL5)*                                                              Triacylglycerol lipase, sterylester hydrolase                                       63.0                   6.83                1,470                                                   Lipid droplets, ER                                      1                       Several
  *TGL3*                                                                     Triacylglycerol lipase, lysoPA acyltransferase                                      73.6                   8.50                3,210                                                   Lipid droplets                                          1                       Few
  *TGL4*                                                                     Triacylglycerol lipase, Ca^++^ dependent phospholipase A2, lysoPA acyltransferase   102.7                  8.05                195                                                     Lipid droplets                                          None                    Several
  *TGL5*                                                                     Triacylglycerol lipase, lysoPA acyltransferase                                      84.7                   9.84                358                                                     Lipid droplets                                          1                       Several
  *UBX2 (SEL1)*                                                              Bridging factor involved in ER-associated protein degradation (ERAD)                66.8                   5.22                12,600                                                  Lipid droplets, ER                                      None                    None
  *USE1 (SLT1)*                                                              SNARE                                                                               28.1                   5.01                973                                                     Lipid droplets, ER                                      1                       None
  *YEH1*                                                                     Sterylester hydrolase                                                               66.5                   6.33                7,770                                                   Lipid droplets                                          1-2                     None
  *YIM1*                                                                     Unknown function                                                                    41.6                   7.98                6,540                                                   Lipid droplets, ER                                      None                    None
  *YJU3*                                                                     Monoacylglycerol lipase                                                             35.6                   8.5                 2,140                                                   Lipid droplets, ER                                      None                    None
  *YPT7 (AST4*, *VAM4)*                                                      Rab family GTPase                                                                   23.0                   4.62                5,530                                                   Lipid droplets, cytoplasm                               None                    None
  *YOR059c*                                                                  Putative lipase                                                                     51.1                   9.81                1,210                                                   Lipid droplets                                          1                       None

Much of the information in this table may be found in the *Saccharomyces* Genome Database. ND, not determined.

[@bib104].

[@bib123]; [@bib114]; [@bib180]; [@bib145]; [@bib229]; [@bib22].

Based on PhosphoGrid (<http://www.phosphogrid.org>) and PhosphoPed (<http://www.phosphopep.org>) Databases.

[@bib114]; [@bib229]; [@bib22].

[@bib262].

Notably, yeast LDs do not contain proteins related to the perilipin family of proteins in mammals ([@bib39]) or oleosins in plants ([@bib54]). Perilipins are prominent LD surface proteins that regulate the access of enzymes to the LD surface during lipogenesis or lipolysis ([@bib39]). Oleosins and related proteins are characteristically shaped proteins that reside on the surface of oil droplets in plant seeds and nonseed tissues and play a role in stress response, hormone signaling, and plant growth and development ([@bib54]). Both types of surface proteins are believed to play important roles in LD biogenesis and structure and lipid mobilization; thus, the question remains how the size of LDs and processes acting on TAG and SE substrates are regulated in yeast in the absence of such LD coat proteins.

Biosynthesis of triacylglycerol and steryl esters {#s6}
-------------------------------------------------

Formation of LD is driven by the synthesis of TAG and SE; in the absence of the biosynthetic capacity to form these lipids, no LD are present and LD-resident proteins may mis-localize to the ER or other intracellular structures and the cytosol ([@bib20], [@bib21]; [@bib64],[@bib65]; [@bib267]; [@bib97]; [@bib258]; [@bib148]). The enzymes involved in TAG and SE metabolism are listed in [Table 1](#t1){ref-type="table"} (see also [@bib134]).

The major substrates for the synthesis of TAG and SE are activated FAs and glycerol-3-phosphate or dihydroxyacetone phosphate (DHAP) and sterols, respectively. The first and rate-limiting step in FA synthesis is catalyzed by acetyl-CoA carboxylase, encoded by *[ACC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299)* ([@bib275]; [@bib11]; [@bib131]; [@bib325]; [@bib134]) ([Figure 2](#fig2){ref-type="fig"}). [Acc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299) converts acetyl-CoA to malonyl-CoA in an ATP, biotin, and CO~2~-dependent reaction. Malonyl-CoA is used by FA synthase, which consists of a hexameric α6β6 complex of two subunits encoded by *[FAS2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006152)* (α-subunit) and *[FAS1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001665)* (β-subunit) for the step-wise elongation of the growing acyl chain ([@bib325]). In contrast to mammalian FA synthase that releases free FAs, the yeast FAS complex generates acyl-CoAs that may be directly channeled into phosphatidic acid (PA), TAG and SE synthesis ([@bib325]; [@bib134]). FA *de novo* synthesis is a major consumer of acetyl-CoA and NADPH, similar to sterol synthesis. Free FAs that are derived from exogenous supply or from endogenous lipid degradation need to be activated by one of five acyl-CoA synthetases, encoded by *[FAA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005844)*, *[FAA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000817)*, *[FAA3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001271)*, *[FAA4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004860)*[,]{.ul} and *[FAT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000245)* genes, which differ in their substrate specificities ([@bib32]). [Faa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000817) is required for the activation of FAs that are directed toward β-oxidation (see below). [Faa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005844), [Faa4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004860), and [Fat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000245) activate exogenously supplied FAs and free FAs that derive from phospholipid, TAG, and SE breakdown. In the absence of these acyl-CoA synthetases, yeast secretes lipolysis-derived FAs ([@bib288]), and growth and membrane lipid composition depend solely on the FAs that are generated by *de novo* synthesis, FA desaturation, and elongation ([@bib325]).

![(A) Metabolic pathways of TAG synthesis and degradation and their subcellular localization (adapted from [@bib173] and [@bib134]). Phospholipids and TAG share DAG and PA as common precursors. In the *de novo* synthesis of phospholipids, PA serves as the immediate precursor of CDP-DAG, precursor to PI, PGP, and PS. PA is dephosphorylated to DAG, which serves as the precursor of PE and PC in the Kennedy pathway. DAG also serves as the precursor for TAG and can be phosphorylated, regenerating PA. The names of the enzymes that are discussed in detail in the text are shown adjacent to the arrows of the metabolic conversions in which they are involved, and the gene--enzyme relationships are listed in [Table 1](#t1){ref-type="table"}. Lipids and intermediates are boxed, with the most abundant lipid classes boxed by bold lines. Enzyme names are indicated in boldface type. TAG, triacylglycerols; PI, phosphatidylinositol; PA, phosphatidic acid; CDP-DAG, CDP-diacylglycerol; DAG, diacylglycerol; MAG, monoacylglycerol; Gro, glycerol; Gluc-6P, glucose-6 phosphate; DHAP, dihydroxyacetone phosphate, PS, phosphatidylserine; FFA, free fatty acids; Ins, inositol. Nucl, nucleus; ER, endoplasmic reticulum; Mito, mitochondria; LD, lipid droplets; G/E/V, Golgi, endosomes, vacuole; Pex, peroxisomes; Cyt, cytoplasma; PM, plasma membrane. See text for details. (B) Metabolic pathways of fatty acid metabolism. FA *de novo* synthesis and elongation: FA (type I) *de novo* synthesis requires the synthesis of malonyl-CoA by the acetyl-CoA carboxylase Acc1. This cytosolic trifunctional enzyme harbors a covalently bound biotin, an N-terminal biotin carboxylase domain, and a C-terminal transcarboxylase domain ([@bib325]). Malonyl-CoA is used by the cytosolic FA synthase complex, consisting of Fas1 (β-subunit) and Fas2 (α-subunit), which are organized in a hexameric α6β6 complex. Fas1 harbors acetyl transferase (AT), enoyl reductase (ER), dehydratase (DH), and malonyl-palmitoyl transferase (MPT) activities; Fas2 contains the acyl carrier protein (ACP), 3-ketoreductase (KR), 3-ketosynthase (KS), and phosphopantheine transferase activities. The product of FA synthesis in yeast is acyl-CoA, typically C14--C16 carbon atoms in length ([@bib325]). Activated FAs may be elongated to VLCFAs by the activity of Elo1, Fen1/Elo2, and Sur4/Elo3 (condensing enzymes); Ybr159w (reductase); Phs1 (dehydratase); and Tsc13 (enoyl-CoA reductase). Yeast also expresses a set of bacterial type II enzymes (as individual polypeptides) that perform the same reactions in mitochondria, but are encoded by nuclear genes ([@bib325]). Mitochondrial FA synthesis presumably generates FA only up to C8, which is a precursor for lipoic acid synthesis. FAs are degraded by β-oxidation. β-oxidation in yeast occurs exclusively in peroxisomes. Medium chain fatty acids enter peroxisomes as free fatty acids (FFA) and are activated by a peroxisomal acyl-CoA synthetase, Faa2. ATP that is required for this activation step is imported into the organelle via Ant1. Long chain fatty acids, such as oleate, are activated outside the organelle by Fat1, Faa1, or Faa4 and taken up as CoA esters (acyl-CoA) via a peroxisomal ABC transporter that consists of the heterodimer Pxa1/Pxa2. Inside peroxisomes, CoA esters undergo dehydrogenation by Pox1, hydratation/dehydrogenation by Fox2, and ultimately thiolytical cleavage by Pot1, leading to acetyl-CoA and an acyl-chain shortened by two carbon atoms. Hydrogen peroxide produced by Pox1 is degraded by peroxisomal catalase T, Cta1. NADH is exported to the cytosol via a malate shuttle that involves peroxisomal (Mdh3) and cytosolic (Mdh2) malate dehydrogenases. The transporter for malate and oxaloacetate has not been identified yet. Acetyl-CoA is transported to the cytosol via carnitine-dependent acetyl-CoA transport (involving Cat2) or via the glyoxylate cycle (see [Figure 5](#fig5){ref-type="fig"}). Unsaturated FAs, such as oleic acid with the double bond between C9 and C10, can be fully oxidized only in the presence of auxiliary enzymes, but the precise mechanism is controversial. Eci1 is a Δ3,Δ2-enoyl-CoA isomerase in the so-called isomerase-dependent major pathway, which catalyzes the positional and stereochemical isomerization of *cis*-3-enoyl-CoA to *trans*-2-enoyl-CoA; this reaction is required after oleic acid (as coenzyme A derivative) has been shortened by three rounds of β-oxidation, since only *trans*-2-enoyl-CoA is a β-oxidation substrate. Eci1 also isomerizes a fraction of *2-trans*, 5-*cis*-dienoyl-CoA to 3,5-dienoyl-CoA, which has two conjugated double bonds in *trans* (3) and *cis* (5) configuration. This compound is presumably degraded by the minor pathway that involves Dci1, Sps19, and Eci1. Alternatively, 3,5-dienoyl-CoA is hydrolyzed by Tes1 thioesterase-dependent pathway) to the free FA and coenzyme A.](1fig2){#fig2}

The central intermediate in glycerolipid metabolism from which TAG and phospholipids are derived is PA ([@bib15], [@bib22]; [@bib173]) ([Figure 2A](#fig2){ref-type="fig"}). PA is synthesized by a two-step acylation reaction: first, glycerol-3-phosphate is acylated by [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) and [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) acyltransferases to *sn1*-acylglycerol-3-phosphate (also termed lyso-PA) ([@bib379]; [@bib376]). Alternatively, [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) and [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) may also acylate dihydroxyacetone phosphate to 1-acyl-DHAP, which is subsequently reduced by the [Ayr1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001386) reductase to *sn1*-acylglycerol-3-phosphate ([@bib17]). The acyltransferases and Ayr are predominantly localized to the ER membrane, but, notably, Ayr and [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) also partially localize to the LD ([@bib22]; [@bib17]; [@bib206]), indicating that at least the first steps in PA synthesis are also LD resident. [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) and [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) acyltransferases exhibit different substrate specificities, giving rise to different populations of phospholipids and TAG molecular species ([@bib376]; [@bib206]).

[Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) and [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) generate lyso-PA, which is further acylated by the ER-resident [Slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210) and [Ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701) acyltransferases to *sn1,2*-diacylgycerol-3-phosphate (PA) ([@bib29]; [@bib56]; [@bib149]; [@bib273]; [@bib134]). [Slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210) and [Ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701) are members of the MBOAT, the membrane-bound *O*-acyltransferase family of proteins and also involved in the Lands cycle of phospholipid acyl-chain remodeling ([@bib140]; [@bib29]; [@bib56]; [@bib149]; [@bib273]; [@bib251]). PA is the central glycerolipid intermediate that is utilized both for TAG and for phospholipid synthesis (for details see [@bib134]). In addition to its role as glycerolipid precursor, PA also plays an important role in regulating cellular lipid metabolism ([@bib134]), and its dephosphorylation to diacylglycerol (DAG) is a key step in driving LD formation ([@bib2]; [@bib92]).

The gatekeeper and major regulator of TAG synthesis---and therefore of LD formation--is the Mg^++^-dependent PA phosphohydrolase, [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775)/[Smp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) ([@bib47], [@bib49]; [@bib126], [@bib127]; [@bib240]; [@bib254]): in the absence of this enzyme in *[pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775)* mutants, TAG synthesis is reduced by at least 70%, which also results in a drastically reduced LD formation ([@bib2]; [@bib92]) ([Figure 1](#fig1){ref-type="fig"}). Mammals express the [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775)/[Smp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) ortholog, lipin (encoded by LPIN1-3 genes), mutations of which may cause lipodystrophy in the mouse ([@bib98]; [@bib61]). Two additional enzymes, diacylglycerolpyrophosphate phosphatase, encoded by *[DPP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002692)* and *[LPP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002911)*, may also be involved in DAG formation; however, they serve a regulatory function and their quantitative contribution to TAG formation is unlikely ([@bib134]).

Diacylglycerol that is formed by dephosphorylation of PA is converted either by the acyl-CoA-dependent acyltransferase [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) \[ortholog of mammalian DGAT ([@bib239]; [@bib281]; [@bib302], [@bib303])\], or the phospholipid-dependent acyltransferase [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291) \[ortholog of mammalian lecithin-cholesterol acyltransferase LCAT ([@bib238])\] to TAG. [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291) localizes to the ER whereas [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) localizes both to the ER and LDs ([@bib229]; [@bib58]; [@bib148]). The primary acyl donors of the [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291)-catalyzed reaction are phosphatidylethanolamine and phosphatidylcholine; thus, this reaction not only contributes to the synthesis of TAG but also serves to remodel the acyl chain composition of these phospholipids ([@bib173]; [@bib142]). Minor contribution to TAG synthesis from DAG stems from the activity of the sterol acyltransferases [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) ([@bib367]) (see below).

The second major neutral lipid components of LD are the SEs. Sterols are synthesized in the ER membrane, which also harbors the acyl-CoA-dependent acyltransferases [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) that are required for SE synthesis ([@bib367]; [@bib370]; [@bib386]) ([Table 1](#t1){ref-type="table"}). [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) share 49% sequence identity with each other, and some 24% identity with mammalian acyl-CoA:cholesterol acyltransferases (ACAT; hence their names **A**CAT-**r**elated **e**nzymes, or Are). Like [Slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210) and [Ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701), [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) are members of the MBOAT family of membrane-bound *O*-acyltransferases ([@bib251]). Notably, both enzymes acylate not only ergosterol, but also intermediates in the ergosterol biosynthetic pathway: whereas the major SE synthase [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) prefers ergosterol as the substrate, [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) has a preference for the sterol precursor, lanosterol, giving rise to distinct SE compositions in mutants lacking either one of the enzymes ([@bib386]; [@bib62], [@bib63]). [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) was also found to contribute most to SE synthesis under anaerobic conditions ([@bib143]).

The localization of the four acyltransferases involved in TAG and SE formation to the ER membrane poses an interesting puzzle as to the transfer mechanism of their products, TAG or SE, to the LD. The close association between the ER and LDs ([Figure 1](#fig1){ref-type="fig"}) may be instrumental in supporting this exchange, but the proteins required for this process are presently unknown. Notably, since also intermediates of the ergosterol biosynthesis are stored as SEs in LD, their mobilization and further processing to "mature" ergosterol requires their reshuffling to the ER-resident sterol biosynthetic enzymes ([@bib82]). The mechanism underlying this transfer and its regulation are unknown.

Turnover of lipid droplets {#s7}
--------------------------

A systematic microscopic analysis in growing cells has shown that LDs are readily degraded and their content mobilized by up to 80% within 4--6 hr after transfer of stationary-phase cells into fresh, glucose-containing media ([@bib183]); the LDs are subsequently replenished until cells reach stationary phase. The neutral lipid content of LD is degraded by the activity of TAG lipases and SE hydrolases. [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930), [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) are members of the conserved patatin-domain-containing family of hydrolases ([@bib18], [@bib19], [@bib20]; [@bib62]; [@bib64],[@bib65]) that are characterized by a serine active residue embedded in a G-x-S-x-G motif in a patatin domain ([@bib164]); however, in contrast to typical lipases that harbor a Ser-Asp-His catalytic triad (see below), these enzymes harbor only a catalytic dyad, composed of a serine and an aspartic acid residue. Yeast [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) is the functional ortholog of the mammalian adipose triglyceride lipase, ATGL ([@bib380]; [@bib183]), which is the major TAG-hydrolyzing enzyme in adipose tissue and in other cell types ([@bib190]; [@bib377]). ATGL deficiency in humans is associated with neutral lipid storage disease with myopathy, NLSDM ([@bib295]; [@bib377]). [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) are the major TAG lipases in yeast, and deletion of these genes leads to markedly increased LD size and number ([Figure 1](#fig1){ref-type="fig"}); [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) only marginally contributes to TAG hydrolysis under standard growth conditions. TAG content is increased by ∼15% in the *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)* mutant, whereas overexpression reduces TAG content \<10% ([@bib18]). However, since TAG content is strongly dependent on growth conditions, somewhat different values were obtained in another study from the same lab, showing that TAG levels in the *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)* mutant increased to 4.11 μg/mg dry cells compared to 1.72 μg TAG/mg dry cells of the wild-type strain (BY4741). [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797)-deficient cells contained 2.97 μg TAG/mg cell dry weight. Notably, whereas [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607)-deficient cells had TAG levels identical to wild type, TAG levels were even further increased in *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)[tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607)* double mutants to 5.38 μg/mg dry weight ([@bib19]).[^2^](#fn2){ref-type="fn"} Not only the quantitative contribution to TAG lipolysis between the yeast lipases differs, but also the lipase substrate specificities differ: [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) preferentially hydrolyzes TAG species containing C14, C16, C20, and C26 saturated acyl chains ([@bib18]). Similarly, [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) prefers TAG species with C14 and C16 acyl chains. Notably, cells lacking the [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) lipase showed markedly increased levels of C26 acyl chain-containing TAG molecular species, indicating a substrate preference of this lipase for very long chain FAs ([@bib19]). In addition to being an efficient TAG lipase, [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) also harbors substantial DAG lipase activity; thus, overexpression of [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) in a *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)* mutant background leads to increased accumulation of DAG, which is also accompanied by a slight growth defect ([@bib183]). [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), in addition to being a major TAG lipase, also displays steryl ester hydrolase and phospholipase A~2~ activities *in vitro*. Furthermore, this enzyme also catalyzes acyl-CoA dependent re-acylation of lyso-PA to PA ([@bib266]). The efficacy of this reaction in contributing to the synthesis of PA *in vivo* is not clear and apparently not sufficient to support growth of an *[slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210)[ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701)* double mutant, lacking the two major yeast lyso-PA acyltransferases (see above). Similarly, [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) lipases also harbor lyso-PA and lyso-phosphatidylethanolamine acyltransferase activities *in vitro* ([@bib265]). Thus, [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930), [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) lipases not only catalyze TAG breakdown to various degrees, but may also be involved in establishing specific acyl-chain compositions to phospholipids.

Despite catalyzing the majority of TAG breakdown, deletion of all three lipases does not result in a significant growth phenotype in logarithmically growing cells ([@bib19]; [@bib183]); however, lipase mutants are sensitive to the FA synthesis inhibitor cerulenin, consistent with the role of lipolysis-derived metabolites (FAs, DAG) for the synthesis of membrane phospholipids. Notably, initiation of the cell division cycle upon transfer of stationary phase/quiescent cells into fresh growth media is delayed in mutants lacking [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) lipases ([@bib184]): in these mutants, G1/S transition is extended by some 30 min, indicating that lipolysis-derived metabolites are required for efficient cell cycle progression (see below). Evidence suggests that lack of lipolysis affects the formation of sphingolipids ([@bib268]), which play multiple regulatory and structural roles ([@bib73]). Also, lipase-deficient mutants are defective in phosphatidylinositol (PI) synthesis: addition of inositol to wild-type cells that were grown in the absence of this lipid precursor results in a rapid burst in PI synthesis, which is significantly attenuated in *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)[tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797)[tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607)* lipase mutants. Additional inhibition of *de novo* FA synthesis by cerulenin abolishes the burst in PI synthesis after inositol addition, indicating that both *de novo*-synthesized FAs and metabolites derived from TAG breakdown are required to support PI synthesis ([@bib101]). PI is also a precursor for the synthesis of complex sphingolipids, which may be the underlying reason for attenuated sphingolipid synthesis in lipase-deficient cells ([@bib268]).

Homozygous diploid *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)/[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)* and *[tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607)/[tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607)* mutants are unable to sporulate, indicating that [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) provide essential activities that are required for the generation of functional spores ([@bib265]). Indeed, it was shown that the [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) acyltransferase activity, rather than the lipase activity, is required for sporulation ([@bib265]). However, the specific step in the sporulation program that requires this activity is not known.

The role of the TAG lipases in sustaining viability during stationary phase, in the absence of other carbon sources, is not known. Notably, mutants defective in the DAG kinase [Dgk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838) also display a delay in growth resumption after transfer of stationary cells into fresh growth medium ([@bib85]), similar to *[tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930)[tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797)* mutants, and TAG degradation is defective, even in the presence of cerulenin. Choline supplementation partially suppresses this defect; it was suggested that lipotoxic lipolysis-derived DAG might accumulate under these conditions, which is drained into the synthesis phospholipids via the cytidine diphosphate (CDP)--choline (Kennedy) pathway if choline is present ([@bib85]). [Dgk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838) is localized to the ER, and the transfer of its substrate DAG from the LDs may be facilitated by the close physical interaction between both organelles ([@bib317]).

Common to [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930), [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) TAG lipases is their exclusive localization to LDs, which is in contrast to other LD proteins---mostly enzymes involved in anabolic processes---that are additionally associated with the ER membrane ([@bib20]; [@bib183]; [@bib64]; [@bib267]; [@bib173]). Localization of [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) to LDs may be regulated by the yeast seipin ortholog [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) ([@bib363]).

In addition to the major TAG lipases [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), which catalyze the majority of TAG and also DAG breakdown, yeast also expresses a monoacylglycerol (MAG) lipase to complete the "lipolytic cascade" analogous to mammalian cells ([@bib377]). Yeast MAG lipase is encoded by the *[YJU3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001577)* gene ([@bib133]) and localizes to both ER and LDs. Deletion of the *[YJU3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001577)* gene results in accumulation of MAG, but does not lead to a detectable phenotype under numerous experimental conditions. This is surprising since the specific activity of the [Yju3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001577) protein is several orders of magnitude higher than that of the TAG lipases ([@bib133]).

The *[TGL1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623)*-, *[YEH1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003935)*-, and *[YEH2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004010)*-encoded steryl ester hydrolases are involved in SE degradation. These enzymes are related to mammalian acid lipases, and, as "prototypic" hydrolases, they harbor a serine-active site embedded in a G-x-S-x-G motif, a catalytic triad consisting of Ser-Asp-His residues, and an α/β-hydrolase fold ([@bib150]; [@bib171]; [@bib223]; [@bib170]; [@bib348]). Whereas [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623) and [Yeh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003935) localize predominantly to LDs, [Yeh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004010) is enriched in the plasma membrane ([@bib171]; [@bib223]; [@bib348]), consistent with previous findings derived from cell fractionation experiments that showed significant SE hydrolase activity in the plasma membrane ([@bib382]; [@bib195]). In addition to its activity as an SE hydrolase, [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623), which shares similarities to mammalian lysosomal acid lipases, also degrades TAG *in vitro*. This activity, however, does not appear to significantly contribute to TAG turnover *in vivo* under standard growth conditions ([@bib150]) and does not affect LD abundance and structure.

Regulation of neutral lipid synthesis {#s8}
-------------------------------------

Very little is known about the specific regulation of enzymes involved in TAG and SE synthesis and, therefore, in LD biogenesis. Formation of LDs is clearly driven by the availability of lipid precursors, sterols, and FAs and therefore is dependent on the regulatory processes that control the biosynthesis of their lipid constituents. Notably, none of these processes has been specifically investigated in the context of LD formation. Microscopic analysis of LD in growing cells indicated that their degradation and new synthesis may be processes that at least partially overlap ([@bib183]). Similarly, dynamic flux balance analysis also unveiled that degradation and *de novo* formation of LD may occur in parallel to maintain FA and lipid homeostasis ([@bib373]). This appears to be a conserved mechanism that also occurs in mammalian cells: FAs taken up from the blood stream into cells may first be incorporated into TAG prior to their release by lipolysis. Failure to degrade TAG in homozygous lipase-deficient ATGL^−/−^ mouse mutants leads to a lack of PPAR-agonist release and impaired mitochondrial function ([@bib124]; [@bib377]).

A major determinant of TAG synthesis is the availability of FAs and glycolysis-derived glycerol-3-phosphate or DHAP. Exogenously supplied FAs are preferentially stored as TAG, but are also incorporated into membrane phospholipids upon FA supplementation ([@bib114]). Very little is known about the regulation of acyl-CoA synthetase activities that are required to activate free FAs ([@bib32]), and it can only be speculated that glycolysis derived glycerol-3-phosphate or DHAP are the limiting compounds that determine cellular TAG levels in the presence of a surplus of exogenous FAs. TAG levels are increased about fivefold when cells are grown in the presence of oleic acid as the sole carbon source ([@bib114]). Endogenous FA synthesis is under transcriptional and post-translational control at the level of [Acc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299) and the FA synthase complex ([@bib325]; [@bib173]; [@bib134]). [Acc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299) is phosphorylated and inactivated by [Snf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002885) kinase, the ortholog of mammalian AMP-activated protein kinase ([@bib365]), under conditions of scarce energy. Thus, [Snf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002885) is an important regulator of TAG homeostasis by regulating the activity of [Acc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299) and, thus, FA *de novo* synthesis and TAG accumulation ([@bib325]). Recent evidence suggests that TOR and [Snf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002885)/AMPK pathways are connected to the control of TAG formation through the [Sit4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002205)-[Sap190](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001736) protein phosphatase complex that may control the activity of [Acc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005299) and/or [Snf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002885) ([@bib37]). FA desaturation is regulated by the membrane-bound transcription factors [Spt23](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001503) and [Mga2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001472), which are processed in an [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) ubiquitin ligase-dependent reaction ([@bib141]; [@bib269]); soluble [Spt23](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001503) and [Mga2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001472) fragments translocate into the nucleus to regulate the expression of the *[OLE1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003023)* gene encoding the single FA desaturase in yeast ([@bib315], [@bib316]; [@bib141]; [@bib55]; [@bib269]; [@bib208], [@bib209]; [@bib325]; [@bib134]). Notably, overexpression of constitutively active [Mga2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001472) or [Spt23](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001503) fragments stimulates TAG synthesis and leads to altered LD morphology, indicating a regulatory link between [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927), [Spt23](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001503), and [Mga2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001472) function and lipid homeostasis ([@bib157]).

The initial steps in glycerolipid synthesis require the activity of [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) and [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) acyltransferases ([Figure 2](#fig2){ref-type="fig"}). [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) localizes to the ER membrane ([@bib41]), and the *[SCT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107)* gene was originally identified as a suppressor of a choline transport mutant, indicating a functional relationship to phosphatidylcholine synthesis ([@bib211]). Indeed, establishment of the acyl-chain composition in phosphatidylcholine requires [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) ([@bib36]). [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) activity, which is regulated by phosphorylation by an as-yet-unknown kinase, competes with the *[OLE1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003023)*-encoded FA desaturase for their common substrate, palmitoyl-CoA. Thus, overexpression of [Sct1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107) leads to increased phosphatidylinositol and TAG levels at the expense of phosphatidylethanolamine and a general shift in FA profiles toward more saturated species ([@bib69]). Notably, deletion of the *[SCT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107)* gene has a significant impact on the turnover of phosphatidylcholine that is generated through the CDP-choline ("Kennedy") pathway ([@bib376]), and further evidence suggests that this phospholipid, next to TAG, functions as a reservoir for FAs, in particular for C16:0 ([@bib69]). This is also consistent with the observation that cells become more sensitive to C16:0 supplementation when both TAG synthesis and the phospholipid methylation pathway are blocked ([@bib97]).

Deletion of the second acyltransferase encoded by the *[GPT2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775)* gene has the opposite effect on phosphatidylcholine turnover than a deletion of *[SCT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000107)*, namely a highly stimulated turnover of this phospholipid synthesized via the CDP-choline pathway ([@bib376]). In contrast to wild-type cells, mutants defective in [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) acyltransferase are sensitive to oleate supplementation and fail to synthesize TAG and induce LD formation ([@bib206]). Oleate may indeed regulate [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775) abundance and its activity by phosphorylation; furthermore, [Gpt2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001775)-containing crescent ER structures that are observed in close vicinity to LDs in the presence of oleate indicate a regulatory crosstalk between LD formation and activity of the initial steps of glycerolipid synthesis ([@bib206]).

The redundant lyso-PA acyltransferases encoded by *[SLC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210)* and *[ALE1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701)* both contribute to the typical FA spectrum in cellular glycerolipids, whereby [Ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701) may have a somewhat higher preference for C16:1-CoA than [Slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210) ([@bib29]). Although [Slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210) harbors the majority of cellular *sn1*-acylglycerol-3-phosphate acyltransferase activity, deletion of either *[SLC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210)* or *[ALE1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701)* genes does not significantly affect total cellular glycerolipid content ([@bib29]). This is surprising since these enzymes together execute an essential reaction, indicated by the synthetic lethal phenotype of *[slc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002210)[ale1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005701)* double mutants, which also suggests the absence of significant additional lyso-PA acyltransferase activities in yeast ([@bib149]).

The dephosphorylation of PA to DAG is considered the rate-limiting step in TAG formation, and mutants lacking the PA phosphatase [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) are characterized by drastically reduced TAG levels ([@bib47], [@bib48]; [@bib126]; [@bib86]; [@bib134]; [@bib254]). [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) is under multiple levels of regulation by phosphorylation, which controls its localization to the cytosol (phosphorylated) or its association with the ER membrane (dephosphorylated) ([@bib48]; [@bib159]; [@bib57]). Dephosphorylation of [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) by the [Nem1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001046)-[Spo7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000007) phosphatase complex favors its association with the ER membrane and facilitates generation of the TAG precursor DAG ([@bib299]; [@bib282]).

Notably, [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) is phosphorylated by the cyclin-dependent protein kinases [Cdc28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364)/[Cdk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364) and [Pho85](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005952) ([@bib159]; [@bib57]), indicating that its membrane association and activity are regulated in a cell cycle-dependent manner. Since TAG degradation also is regulated in a cell cycle-dependent manner ([@bib184]) (see below), the picture emerges that TAG synthesis and degradation may indeed oscillate during the cell cycle ([@bib184]; [@bib173]).

The activity of [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) is counteracted by the CTP-dependent diacylglycerol kinase [Dgk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838) and may thus contribute to the regulation of TAG homeostasis. Overexpression of the *[DGK1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838)* gene results in proliferation of ER membranes, consistent with an overproduction of PA that is preferentially channeled into phospholipid synthesis ([@bib128],[@bib129]). Whereas the impact of *[DGK1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838)* overexpression on cellular TAG levels is unclear, deletion of this gene hardly has any affect on cellular TAG content in growing cells. However, [Dgk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838) activity is important during periods of growth resumption, *i.e.*, after transfer of stationary-phase cells to fresh media, presumably to convert lipolysis-derived DAG to PA and subsequently to phospholipids. Absence of [Dgk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005838) activity leads to the accumulation of DAG with potentially detrimental effects on the cells, which can be attenuated by utilizing DAG for the CDP-choline pathway in the presence of choline ([@bib85]).

The specific regulatory mechanisms that control the activity of [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771), [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291), [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644), and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) acyltransferases are unknown ([@bib367]; [@bib238], [@bib239]; [@bib386]; [@bib302]). Mutant analysis indicates that [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) contributes more significantly to TAG synthesis in the stationary phase, whereas [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291) apparently is more active during logarithmic growth ([@bib239]). Notably, supplementation of wild-type cells with oleic acid, which stimulates TAG synthesis, simultaneously reduces cellular SE levels ([@bib60]). This observation indicates a regulatory crosstalk between TAG synthesis and SE synthesis, the molecular basis of which, however, has not been uncovered yet. These findings also raise the question of whether distinct types of yeast LDs that harbor either SE or TAG may exist (see below). Clearly, biophysical properties differ between SE- or TAG-only LDs, despite similar size distribution ([@bib63]). For example, tri-oleoyl glycerol and tri-palmitoleoyl glycerol, which are the major TAG species, have a melting point below --4°, whereas cholesteryl oleate (related to the yeast ergosteryl oleate) has a melting point above +40° (PubChem Substance database).

Acylation of sterols may regulate the flux through the ergosterol biosynthetic pathway by sequestering and storing intermediate products as SEs in the LD. Thus, acylation may prevent buildup of potentially harmful sterol intermediates. Sterol synthesis is under a tight feedback regulatory loop that controls the expression of HMG-CoA reductase, the key enzyme of sterol synthesis both in yeast and in mammals ([@bib82]; [@bib46]; [@bib270]). Mutants lacking [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771), [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291), [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644), and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) acyltransferases altogether display a defect in sterol synthesis, which is due to the reduced amount of squalene epoxidase, [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) ([@bib304]). This reduction in [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) abundance is not due to attenuated expression but rather is a result of decreased protein stability in the *[dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771)[lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291)[are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644)[are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302)* quadruple mutant. [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) typically localizes both to the ER and LDs ([@bib196]), which, however, are absent in the quadruple mutant. Thus, the decreased [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) stability indicates a tight regulation of the amount of ER-resident [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) protein. It furthermore suggests that localization of [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) to the LD provides a mechanism to store (catalytically inactive) enzyme that is not subject to this regulation ([@bib196]), but may be relocalized to the ER upon metabolic requirements. The mechanisms that govern sterol lipid exchange between the ER and LDs, and the regulation of these processes, remain obscure.

TAG accumulation is also influenced by the cellular capacity to synthesize phospholipids: attenuated phosphatidylcholine synthesis, *i.e.*, in mutants lacking the *[CHO2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003389)*- and *[OPI3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003834)*-encoded phospholipid methyltransferases or defective in *S*-adenosylhomocysteine hydrolase ([Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845)), which affects the methylation activity, leads to an increased synthesis of TAG and LD proliferation ([@bib202]). The reduced flow of FAs into phosphatidylcholine synthesis presumably leads to the accumulation of PA, which is preferentially channeled into the synthesis of TAG. However, these observations also support the notion that PC synthesis, in addition to TAG, may also provide some (limited) buffering capacity for accommodating excess FA.

Regulation of neutral lipid degradation {#s9}
---------------------------------------

Lipolysis is most active during growth resumption of stationary-phase cells that are transferred into fresh, glucose-containing medium ([@bib183]; [@bib373]). TAG is degraded by [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) lipases that both reside on the lipid droplet ([@bib62]; [@bib64]; [@bib267]; [@bib173]; [@bib134]). Neither protein abundance nor localization appear to change during the phase of lipolysis. [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) and [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623), which are also TAG lipases *in vitro*, do not appear to contribute significantly to TAG degradation. Indeed, [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623) is more active as a SE hydrolase ([@bib171]). [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) is phosphorylated and activated by the cyclin-dependent kinase [Cdk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364)/[Cdc28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364) ([@bib184]) at the G1/S transition of the cell cycle, suggesting that lipolysis-derived products (*i.e.*, FAs or DAG) are required to drive cell cycle progression. The specific checkpoint-monitoring availability of lipolysis products is unknown. Similarly, [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) may also be a substrate of [Cdk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364)/[Cdc28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364) ([@bib333]), and [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) lipase is a potential target of the second, nonessential cyclin-dependent kinase [Pho85](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005952), according to large-scale studies ([@bib263]). Whether [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005607) activities are indeed regulated during the cell cycle is not known.

The observation that lipolysis in yeast is linked to cell cycle progression is unexpected; indeed, [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) and [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) are among the very few direct enzymatic targets of the cyclin-dependent kinase [Cdk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364)/[Cdc28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000364). Since both *de novo* TAG synthesis, driven by the activity of PA phosphatase [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775), and lipolysis are regulated in a cell cycle-dependent manner, it becomes obvious that maintenance of lipid homeostasis during the cell cycle is critical ([@bib184]; [@bib173]). Neither the TAG degradation products nor the checkpoint regulator that senses their availability are known. Notably, [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) phosphorylation---and activation---occurs at the G1/S transition of the cell cycle, at bud emergence, whereas [Pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775) phosphorylation---and inactivation---occurs at the G2/M transition. This leaves both enzymes active during a large part of the cell cycle, consistent with a model that lipogenesis and lipolysis may occur in parallel to sustain cellular lipid homeostasis ([@bib373]; [@bib173]).

The mechanisms of the regulation of steryl ester hydrolysis by [Yeh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003935), [Yeh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004010), and [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623) are currently unknown. Since LDs that are composed of about equal amounts of TAG and SEs are mobilized by 80% during the initial phase (∼6 hr) of growth resumption ([@bib183]), one can assume the highest activity of these enzymes during this period of growth. The LD-resident enzymes [Yeh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003935) and [Tgl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001623), but not the plasma membrane-resident enzyme [Yeh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004010), harbor potential cAMP-dependent protein kinase A phosphorylation sites, which may be responsible for stimulation of activity ([@bib171]). Also, [Yeh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003935) is the major SE hydrolase in *[hem1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002640)*-deficient mutant cells that lack *de novo* sterol synthesis and require ergosterol supplementation ([@bib170]).

Mechanisms of LD biogenesis and inheritance {#s10}
-------------------------------------------

No clear picture currently exists of how LDs are actually assembled, neither in yeast nor in other cell types. Current models of LD formation are summarized in [Figure 3](#fig3){ref-type="fig"} ([@bib385]; [@bib221]; [@bib62]; [@bib64]; [@bib148]) (see below). The "lensing" model ([Figure 3A](#fig3){ref-type="fig"}) and the "bicelle" model ([Figure 3B](#fig3){ref-type="fig"}) share the idea that TAG accumulates between the leaflets of the ER membrane; after reaching a critical size, LD may bud off toward the cytosol (lensing model) or are excised from the ER, leaving behind a gap in the membrane, which, however, may be quickly filled up again. In the former model, the monolayer surrounding the LD is solely derived from the cytosolic leaflet of the ER membrane, whereas in the bicelle model both ER membrane leaflets contribute to the LD surface monolayer. The "vesicle budding" model ([Figure 3C](#fig3){ref-type="fig"}) suggests the formation of TAG-filled secretory vesicles that undergo remodeling of the ER-derived phospholipid bilayer to yield the observed phospholipid monolayer covering the LDs. Common to these models is a tight functional interaction between emerging LDs and the endoplasmic reticulum from which they presumably derive. Indeed, LDs may be in continuous ER contact throughout their life cycle ([@bib363]). Recently, first attempts have been made to understand LD formation from a theoretical point of view, based on biophysical models ([@bib374],[@bib375]). According to these models, LDs bud off the ER membrane in a process that is driven by lipid de-mixing in the membrane, when a critical size of some 12 nm is reached. Since this size is more than an order of magnitude below the observed LD size *in vivo*, the authors concluded that LD formation is a two-step process in which initial LD formation is followed by fusion events, giving rise to native "ripe" LDs ([@bib374],[@bib375]).

![Models of lipid droplet biogenesis (adapted from [@bib119]. (A) According to the "lensing model," neutral lipids are deposited between the leaflets of the ER membrane: after reaching a critical size, the neutral lipid core bulges out and the LD is formed; the LD surface monolayer is derived solely from the cytosolic leaflet of the ER membrane. Subsequently, the LD may completely separate from the ER membrane, or remain attached, with the surface layer forming a continuum with the ER. (B) Bicelle formation: LD formation similar to model in A, but the LD is excised from the ER membrane, and both ER membrane leaflets contribute to the LD surface monolayer. (C) Vesicle formation. Inclusion of the neutral lipid core in the membrane vesicle requires rearrangement of the inner leaflet of the bilayer. These models explain the origin of the phospholipid membrane, which stems either from the cytoplasmic leaflet or from both leaflets of the ER membrane, respectively. Unclear is what limits the expansion of the neutral lipid core between the leaflets, what determines the orientation of LD extrusion toward the cytosol, and how the integrity of the ER membrane is maintained. Notably, none of the intermediate stages representing neutral lipid deposits between the ER membrane leaflets, nascent lipid droplets in the ER, or lipid-filled vesicular structures have been experimentally observed in wild-type cells.](1fig3){#fig3}

Contribution of acyl transferases to LD biogenesis {#s11}
--------------------------------------------------

In the absence of both DAG acyltransferases, [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) and [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291), LDs are solely composed of SE. Notably, despite the fact that SE make ∼50% of the total neutral lipid content in wild-type cells, LD numbers are drastically reduced in *[dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771)[lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291)* double mutants to one or two LDs ([@bib239]; [@bib302]; [@bib20]; [@bib62]; [@bib65]; [@bib267]; [@bib349]; [@bib173]) ([Figure 1](#fig1){ref-type="fig"}). In contrast, simultaneous deletion of [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) sterol acyltransferases has only a marginal effect on LD content. No LDs are present in mutants lacking [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291) [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) acyltransferases ([@bib239]; [@bib281]; [@bib97]; [@bib258]; [@bib173]). Thus, LD formation is clearly correlated with the activity of these acyltransferases. This has also led to the establishment of a test system to study LD biogenesis by expressing the major DAG acyltransferases, [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) or [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291), under control of the galactose-inducible *[GAL1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000224)^p^* promoter, in cells lacking other acyltransferases ([@bib148]). In this system, LDs are absent from cells grown on glucose, but LD formation is induced upon shift of cells to galactose medium; LD formation could be observed within 2 hr of induction of the acyltransferases. Formation of new LDs occurs close to the nuclear ER, consistent with the current biogenesis model that LD may derive from the ER. Furthermore, LD proteins that relocalize to the ER in the absence of LDs translocate to the newly formed, nascent LD; this protein relocalization is independent of *de novo* protein synthesis or energy ([@bib148]). Fluorescence recovery after photobleaching and fluorescence loss in photobleaching experiments suggest that ER and LD membrane may indeed form a continuum that allows the free diffusion of LD-resident proteins from the ER to the growing LD, and back to the ER, upon stimulation of TAG breakdown ([@bib148]).

The topology of acyltransferases involved in TAG formation may provide some clues as to the origin of the LD core lipids and thus the mechanism of LD formation ([@bib58]; [@bib148]; [@bib251]). [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) harbors a stretch of hydrophobic amino acids compatible with two membrane-spanning domains; since the enzyme is active both in the ER and on LDs, which contain only a phospholipid monolayer, any potential rearrangement of the enzyme does not appear to affect its activity ([@bib148]). In contrast, [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291), the phospholipid-dependent acyltransferase, which is exclusively localized to the ER, harbors only one membrane-spanning domain. Its presumed active site residing in the lumen of the ER suggests that TAG may indeed be formed in the lumen of the ER, rather than between ER membrane leaflets ([@bib58]). Similarly, evidence suggests that in the MBOAT enzymes [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302), the conserved histidine residue involved in catalysis is also exposed to the luminal side of the ER ([@bib251]).

Targeting of proteins to LDs {#s12}
----------------------------

Unlike other proteins targeted to organelles, LD-associated proteins apparently do not harbor targeting consensus sequences as determined by primary structure comparison of LD-associated proteins. However, a common feature appears to be the presence of hydrophobic domains, although exceptions exist ([@bib196]; [@bib222]; [@bib114]). As shown in [Table 1](#t1){ref-type="table"}, several of the LD-associated proteins contain even one or two (predicted) transmembrane domains, which appear to be incompatible with the generally accepted view that the LD surface is covered by a phospholipid monolayer. Thus it is unclear how these extended stretches of hydrophobic amino acids are accommodated in the LD surface layer. Also, numerous LD proteins lack hydrophobic stretches indicative of membrane-anchoring sequences altogether ([Table 1](#t1){ref-type="table"}), suggesting that their interaction with LDs may be indirect and through the interaction with LD-anchored proteins.

Notably, numerous LD-associated proteins are dually localized also to the ER membrane ([Table 1](#t1){ref-type="table"}), including the enzymes involved in sterol synthesis [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407), [Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467), and [Erg7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001114) ([@bib222]). The physiological relevance of this dual localization is unclear, since the other enzymes of ergosterol biosynthesis are ER-resident; However, as shown for [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407), localization to the LD may serve a regulatory function---to provide a pool of enzyme that is inactive on the LD, but which may readily relocalize to the ER upon demand ([@bib304]). Truncated versions of the [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) lacking a single C-terminal hydrophobic stretch of 55 amino acids lost their affinity to the LDs and relocalized prodominantely to the ER. Deletion of 87--139 C-terminal amino acids of the [Erg7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001114) protein also led to significant retention of protein in the ER and reduced association to LDs. A C-terminal deletion of 26 hydrophobic amino acids in [Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467) did not significantly alter its localization, whereas a deletion of 66 C-terminal amino acids abolished LD association and led to full translocation of the truncated [Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467) protein to the ER ([@bib222]). It should be noted, however, that the relative distribution of proteins to the ER and LDs might depend on protein abundance, which somewhat limits the use of episomal overexpression clones for LD localization studies. Apparently, hydrophobic stretches are required for LD association, but the factors that discriminate relative distribution to LDs and the ER are currently unknown. Notably, heterologous LD proteins expressed in yeast also localize faithfully to LDs, such as mammalian adipose triglyceride lipase, ATGL ([@bib183]), or methyltransferase like 7B (AAMB) ([@bib378]), despite the absence in yeast of perilipins that play an important role in regulating the access of proteins to the LDs in mammals ([@bib39]).

Lipid droplet morphology and inheritance {#s13}
----------------------------------------

Notably, in a given population of cells, LD size distribution is quite homogeneous, and it is currently unclear which factors regulate LD size independently of neutral lipid composition ([@bib63]). Yeast expresses the protein [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) that is distantly homologous to mammalian seipin, implicated in the serious inheritable Berardinelli--Seip congenital lipodystrophy type 2 that results from defects in the BSCL2 gene ([@bib317]; [@bib89], [@bib90],[@bib91]). Mutations in the *[FLD1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396)* gene lead to "supersized" LDs under inositol-limiting conditions, indicating that [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) may play a role in LD biogenesis and organization. Indeed, morphological analysis in growing yeast cells indicates that [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) plays a role in LD subcellular distribution and inheritance ([@bib363]). Furthermore, access of the TAG lipase [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) to LDs seems to be impaired in *[fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396)* mutants. Its role in LD formation is derived from observations that [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) may form homo-oligomers and localizes at the interface between the ER membrane and LDs ([@bib317]; [@bib31]). Thus, although not itself an LD-resident protein, [Fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396) is a potential regulator of LD assembly.

Physiological role of LDs {#s14}
-------------------------

LDs function as the storage depot for TAG and SE. Thus, processes that depend on TAG and SE formation, or metabolites derived from TAG or SE, are affected by the cell's capacity to generate LDs. LDs lacking SE are more sensitive to sterol synthesis inhibitors, such as terbinafine ([@bib386]), which is in line with the function of SE as storage molecules. In the presence of sterol synthesis inhibitors, SE are degraded and sterols incorporated into membranes until the SE content of the cell is exhausted and growth ceases ([@bib386]). Similarly, inhibition of FA *de novo* synthesis by cerulenin results in rapid mobilization of TAG and the utilization of released FAs or DAG for membrane lipid synthesis ([@bib183]; [@bib85]).

A second major function of TAG (and LDs) is to serve as a buffer to "neutralize" excess FA. Cells lacking the capacity to synthesize TAG, *i.e.*, *[dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771)[lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291)[are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644)[are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302)* quadruple mutants, are highly sensitive to supplementation with unsaturated FAs: in the absence of TAG formation, oleic acid is preferentially incorporated into phospholipids, which leads to massive membrane proliferation and rapid loss of viability ([@bib174]; [@bib97]; [@bib258]). This also reflects the sensitivity of mammalian cells to FA overload ([@bib200]; [@bib287]). Notably, quadruple mutants exposed to oleic acid appear to "adapt" to this challenge and recover after an extended lag period ([@bib60]). This adaptation, however, seems to be a stable trait and suggests the appearance of suppressor mutations that allow cells devoid in TAG synthesis to sustain oleic acid challenge. Indeed, mutations in mitochondrial DNA confer resistance of the quadruple mutant to oleic acid-induced cell death ([@bib274]). Similarly to the quadruple mutant that lacks TAG altogether, *[pah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004775)* mutants lacking PA phosphatase and containing drastically reduced levels of TAG are also highly sensitive to unsaturated FA supplementation ([@bib86]). Thus, the picture emerges that FA overload leads to a critical imbalance in cellular phospholipid composition in the absence of TAG synthesis ([@bib174]; [@bib97]; [@bib172]).

As mentioned above, attenuation of phosphatidylcholine synthesis in *[cho2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003389)[opi3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003834)* mutants or in mutants defective in *S*-adenosylhomocysteine hydrolase, which regulates the cellular methylation potential ([@bib202]; [@bib323]), leads to an increased flux of FAs into TAG and subsequent LD accumulation. Notably, levels of phosphatidylcholine can be substantially reduced in yeast cells without leading to a significant growth phenotype ([@bib134]), indicating that this phospholipid may also serve, at least in part, as a buffer for FAs. Similarly, a block of the early secretory pathway that can also be considered as a process to regulate the metabolic flux of phospholipids out of the ER leads to elevated TAG levels ([@bib100]). These observations support the notion that phospholipid and TAG metabolism are metabolically tightly interconnected and that inactivation of either biosynthetic branch forces the channeling of FAs into the other, with potentially detrimental consequences for the cell. Furthermore, TAG and LD formation appear to play a crucial role in modulating ER stress that is induced by altered phospholipid composition or turnover ([@bib130]).

In addition to serving as an overflow reservoir for excess FAs, TAG---and LD altogether---may also serve as an overflow storage compartment for proteins. For example, [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) is a prominent protein residing on LDs, but inactive in the absence of the ER-resident reductase ([@bib196]). Thus, localization of [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) to LD may serve as a reservoir to control the catalytic capacity of the ER-resident sterol biosynthetic pathway. Absence of LDs leads to relocalization of [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) to the ER membrane and its partial degradation to regulate the concentration of [Erg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003407) in the ER ([@bib304]).

Notably, induction of LDs was observed in cells expressing mammalian α-synuclein ([@bib249]). α-Synuclein is implicated in neurogenerative diseases, such as Parkinson's and Alzheimer's, and its expression in yeast is toxic and leads to impaired vesicular trafficking and inhibits phospholipase D expression ([@bib249]). Notably, yeast quadruple mutants lacking [Dga1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005771) [Lro1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005291) [Are1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000644) and [Are2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005302) acyltransferases and, therefore, LDs altogether (see above) are more resistant to α-synuclein expression ([@bib296]). In the quadruple mutant, the basal levels of reactive oxygen species ([@bib296]) as well as unfolded protein response ([@bib258]) are elevated in the absence of neutral lipid synthesis; thus it was suggested that upregulated oxidative defense mechanisms may protect LD-deficient cells from α-synuclein toxicity. Notably, the sterol precursor, squalene, may play an important role in oxidative stress defense ([@bib296]). Squalene accumulates in LDs, but also in subcellular membranes, when LDs are absent ([@bib307], [@bib308]).

Physiological interaction of LDs with other organelles {#s15}
------------------------------------------------------

It is currently unclear whether and how TAG homeostasis and peroxisome (PEX) function (see *Peroxisomes*) are coupled in yeast, despite their apparent close physical interaction *in vivo* ([@bib30]). A physiological interaction between these organelles may be restricted to FA β-oxidation, which, in *S. cerevisiae*, occurs exclusively in peroxisomes and is absent from mitochondria, which are the major site of β-oxidation in mammalian cells. [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) lipases are not required for induction of peroxisome formation after glucose depletion in the absence of exogenous FA supplementation ([@bib258]). By using bi-molecular fluorescence complementation, [@bib264] identified several interactions of LD-resident proteins with peroxisomal and mitochondrial proteins, indicating their direct physical interaction. This analysis technique is based on the reconstitution of a fluorescent protein (Venus) from two nonfluorescent fragments that is driven by the interaction of two proteins fused to these fragments. Most significant interactions were observed for the LD-resident [Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467) and [Pet10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001754) with other LD proteins, but also with mitochondrial and peroxisomal proteins ([@bib264]). According to this analysis, [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) lipase interacts with the [Ayr1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001386) protein that catalyzes the reduction of *1*-acyl-DHAP to lyso-PA ([Figure 2](#fig2){ref-type="fig"}), thus indicating a feedback loop between lipolysis and *de novo* glycerolipid synthesis. Furthermore, the interaction of the TAG lipase [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) with the peroxisomal protein [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) is consistent with the concept of metabolic channeling of TAG-derived FAs to peroxisome biogenesis and β-oxidation.

Yeast as a model to investigate and understand lipid-associated disorders {#s16}
-------------------------------------------------------------------------

The pandemic development of obesity and related disorders, such as cardiovascular disease and type 2 diabetes, has led to significant efforts to study the molecular basis of lipid-associated disorders in various experimental model systems, including mice, worms, flies, and yeast. The similarities in the metabolic pathways involved in TAG and SE metabolism between yeast and "larger" cells make yeast an attractive experimental system to study lipid function and malfunction at the molecular and cellular levels ([@bib174]; [@bib172],[@bib173]; [@bib377]). Although lipid-associated disorders typically affect multiple organs and cell types, fundamental insights into key factors of mammalian TAG synthesis have been generated in yeast, *e.g.*, by the discovery of lipin function as a phosphatidic acid hydrolase. Lipin is a protein known for a long time to be implicated in lipodystrophies in mouse model systems ([@bib257]; [@bib47]; [@bib271]; [@bib61]; [@bib125]), yet its enzymatic function was identified by studies in yeast ([@bib126], [@bib127]; [@bib240]; [@bib50]).

[Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845), a key enzyme in methylation metabolism, is one of the most highly conserved proteins, sharing some 60% sequence identity between yeast and the mammalian enzymes ([@bib324]; [@bib202]; [@bib323]). Notably, the *[SAH1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845)* gene in yeast was found to be transcriptionally coregulated with phospholipid biosynthetic genes, indicating a functional link between methylation and lipid metabolism. Indeed, phospholipid methylation is a major consumer of *S*-adenosylmethionine (AdoMet), leading to the accumulation of *S*-adenosylhomocysteine (AdoHcy) as a by-product, which also acts as a potent product inhibitor. [Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845) is responsible for the degradation of AdoHcy to adenosine and homocysteine, thus regulating the cellular methylation potential ([@bib323]); however, this reaction is reversible, and an accumulation of homocysteine may, in fact, drive the formation of the methylation inhibitor, AdoHcy. This puts the risk factor for atherosclerosis, homocysteine, into a new perspective, as a regulator of cellular methylation by its [Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845)-dependent conversion to AdoHcy ([@bib323]). Since [Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845) is an essential enzyme, studies in mouse model systems are very limited due to embryonic lethality of the *ko* mutation. On the other hand, mammalian [Sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845) complements a yeast *[sah1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000845)* deletion, providing an attractive experimental system for studies on structure--function relationships ([@bib202]; [@bib323]).

A high level of functional of structural conservation was also observed for the "lipolytic cascade," a sequence of enzymatic steps that results in complete TAG degradation via DAG and MAG to glycerol and free FAs ([@bib183]; [@bib377]). These reactions are governed in yeast by the [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) TAG lipases, of which [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930) also harbors DAG lipase activity ([@bib183]); the final step of MAG hydrolysis is catalyzed by [Yju3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001577) in yeast ([@bib133]). In mammals, ATGL is responsible for TAG breakdown to DAG, which is further subject to degradation by hormone-sensitive lipase and monoacylglycerol lipase. Notably, [Tgl3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004930), [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797), and ATGL are members of the patatin-domain-containing family of enzymes ([@bib164]), and [Tgl4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001797) deficiency in yeast can be functionally complemented by mouse or human ATGL, which also correctly localize to the LD, despite the absence of perilipins in yeast that regulate access of ATGL to LDs in mammalian cells ([@bib183]). Lypolysis clearly not only provides FAs for β-oxidation and energy production but also generates TAG-derived signaling molecules important for mitochondrial function in mammals ([@bib377]) or cell cycle progression in yeast ([@bib184]).

Many of the enzymes involved in TAG synthesis have orthologs in mammals and are now extensively studied with respect to their topology in the ER membrane and with respect to their contribution to LD formation ([@bib58]; [@bib148]; [@bib251]). A class of proteins implicated in TAG storage and LD biogenesis are the mammalian FIT proteins \[fat storage-inducing transmembrane proteins ([@bib153]; [@bib115], [@bib116]; [@bib217])\], of which two orthologs exist in yeast, encoded by *[SCS3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003094)* and *[YFT2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002727)*. Yeast mutants lacking [Scs3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003094) are inositol auxotrophs, indicating a functional link to the transcriptional regulation of phospholipid synthesis ([@bib134]); however, their specific roles in TAG metabolism and LD formation in yeast are unknown. Large-scale interaction studies indicate that both *[SCS3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003094)* and *[YFT2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002727)* have shared and unique functions and may be required for ER membrane biosynthesis in response to perturbations in lipid metabolism and ER stress ([@bib217]). In two independent imaging-based screens, [@bib89], [@bib91]) and [@bib317] identified yeast mutants with aberrant LD morphology ("supersized LDs") that are defective in the *[FLD1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396)* gene. *[FLD1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396)* is an ortholog of the mammalian BSCL2 gene encoding seipin that is associated with severe inherited Berardinelli--Seip congenital lipodystrophy type 2 ([@bib3]; [@bib4]; [@bib99]). Notably, the supersized LD phenotype in yeast *[fld1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004396)* mutants can be complemented by mammalian wild-type BSCL2, supporting the high level of functional conservation in mammals and yeast ([@bib89], [@bib91]).

In addition to the lipogenic and lipolytic pathways, the major regulatory and signaling processes, such as TOR and AMPK/[Snf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002885), are also conserved in yeast ([@bib372]; [@bib70]) and apparently are connected to lipid homeostasis ([@bib37]); however, this "lipid connection" clearly needs further exploration. Notably, many yeast wild-type strains significantly differ in their LD content, but the genetic basis for these diverse lipid phenotypes is not known. This observation clearly reflects the polygenic nature of lipid and energy metabolism in mammals and requires QTL analysis to obtain further insight into the specific contributions of genes and pathways to cellular lipid homeostasis.

Peroxisomes {#s17}
===========

Microbodies were first described on the basis of their simple morphology in mouse renal tubule cells by [@bib272]. Later, biochemical functions could be attributed to these organelles, and they were functionally subdivided into peroxisomes (containing at least one hydrogen peroxide-producing oxidase and catalase), glyoxysomes (containing enzymes of the glyoxylate cycle) ([@bib330]), glycosomes (harboring glycolytic enzymes, observed only in trypanosomes) ([@bib244]), Woronin bodies that are involved in plugging of septal pores in filamentous ascomycetes ([@bib72]), and hydrogenosomes (producing hydrogen, observed only in anaerobic fungi) ([@bib210]). Of these, peroxisomes were first characterized as organelles implicated in hydrogen peroxide metabolism. However, today various other peroxisomal functions are known (for reviews see [@bib236]; [@bib336]; [@bib352]), including biosynthetic \[*e.g.*, in secondary metabolite biosynthesis ([@bib26])\] and non-metabolic ones \[*e.g.*, in the innate immune response ([@bib192])\].

In yeast, the morphology of microbodies was described for the first time in *S. cerevisiae* by [@bib23]. However, it took almost 20 years before collaborative efforts of the groups of Veenhuis and Kunau demonstrated that peroxisomes play a crucial role in oleate metabolism in *S. cerevisiae* and that, consequently, these organelles are massively induced during growth of yeast on oleate as the sole carbon and energy source ([@bib344]). These findings opened a new era in peroxisome research, which contributed to the identification of the first *PEX* genes ([@bib80], [@bib81]) involved in peroxisome development. This information subsequently allowed unraveling of the principles of human peroxisome biogenesis disorders because of the strong conservation of the molecular mechanisms of peroxisome development between lower and higher eukaryotes.

Peroxisome composition {#s18}
----------------------

Peroxisomes consist of a single membrane encompassing a protein-rich matrix. A typical feature of peroxisomal membranes is their low protein content, which is supported by their very smooth fracture faces in freeze-etch replicas ([Figure 4A](#fig4){ref-type="fig"}). The peroxisomal matrix is generally considered to represent the site of the highest protein concentration in eukaryotic cells. Indeed, peroxisomes are the highest density organelles after density gradient centrifugation of post-nuclear cell homogenates. The high protein concentration in these organelles often results in the formation of electron dense inclusions or protein crystalloids in the peroxisomal matrix, *e.g.*, in peroxisomes of plants or methylotrophic yeasts. However, in wild-type *S. cerevisiae* this is never observed ([Figure 4D](#fig4){ref-type="fig"}): in this organism, peroxisome proliferation is induced by oleate and strongly repressed by glucose ([Figure 4, C and D](#fig4){ref-type="fig"}). Repression of peroxisome proliferation is especially evident in certain *S. cerevisiae* strains such as G910 ([@bib344]). These cells contain only one or very few peroxisomes during exponential growth on glucose ([Figure 4C](#fig4){ref-type="fig"}), in contrast to oleate-grown cells in which the abundance and size of peroxisomes is strongly increased ([Figure 4D](#fig4){ref-type="fig"}). However, in various currently used strains, peroxisome numbers in glucose-grown cells are only slightly lower compared to cells grown on oleate ([Figure 4, E and F](#fig4){ref-type="fig"}; *S. cerevisiae* BY4742).

![Morphological characteristics of yeast peroxisomes. (A) Freeze-etch replica of oleic acid-grown *S. cerevisiae* cells showing the fraction faces of the different organelles. Peroxisomes contain very smooth fracture faces, indicative of a low abundance of integral membrane proteins. (B) Thin section of a cell grown on oleic acid cytochemically stained for catalase activity, using diamino-benzidine and hydrogen peroxide. In these cells, numerous stained, electron-dense peroxisomes are present. Staining of the mitochondrial cristae is due to cytochrome c peroxidase activity. Ultrathin sections of (C) glucose-grown and (D) oleic acid-grown and KMnO~4~-fixed *S. cerevisiae* G910 cells ([@bib344]). The cell grown on glucose displays only a few very small peroxisomes (arrows), whereas strong peroxisome proliferation is evident in the oleic acid-grown cell. (E and F) Fluorescence microscopy of (E) glucose-grown and (F) oleic acid-grown cells expressing GFP-SKL to label peroxisomes in wild-type strain BY4742. Notably, in this strain background, the difference in peroxisome number on glucose and oleic acid media is far less pronounced compared to strain G910. N, nucleus; M, mitochondrion; P, peroxisome; V, vacuole; LD, lipid droplet. Scale bar: 200 nm in A, 1 μm in B--D, and 3 μm in E and F.](1fig4){#fig4}

The peroxisomal matrix almost exclusively contains enzymes, which generally harbor cofactors and are mostly oligomeric. Peroxisomal membrane-bound enzymes are rare. This may explain the relatively low membrane surface/volume ratio and the very low protein/phospholipid ratio of peroxisomal membranes. All characterized peroxisomal membrane proteins (PMPs) are involved in peroxisome biogenesis and dynamics or in solute transport processes; protein modifications, such as glycosylation or phosphorylation, have been reported for only a few PMPs and are absent from matrix proteins.

The *Saccharomyces cerevisiae* Genome Database currently contains 66 proteins that have been demonstrated to reside at peroxisomes (listed in [Table 2](#t2){ref-type="table"}). Of these, 24 encode enzymes, whereas only 3 represent membrane transporters for solutes. The remaining proteins are peroxins or proteins involved in various other peroxisomal processes, such as fission or inheritance ([Table 2](#t2){ref-type="table"}).

###### Peroxisomal proteins

  Gene                                                        Required for growth on oleate   Expression induced by oleate   Enzyme/activity                                                                                                                            Molecular mass (kDa)   Isoelectric point   Molecules per cell[*^a^*](#t2n1){ref-type="table-fn"}   Localization[*^b^*](#t2n2){ref-type="table-fn"}    Function
  ----------------------------------------------------------- ------------------------------- ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------- ------------------- ------------------------------------------------------- -------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------
  **β-Oxidation enzymes**                                                                                                                                                                                                                                                                                                                                                                                                     
  *PCS60 (FAT2)*                                              No                              Yes                            Medium chain fatty acyl-CoA synthetase                                                                                                     60.5                   9.98                8,770                                                   Peripheral peroxisomal membrane and matrix         Activates fatty acids with a preference for medium chain lengths, C9--C13
  *FAT1*                                                      No                                                             Very long chain fatty acyl-CoA synthetase and long chain fatty acid transporter                                                            77.1                   8.47                16,900                                                  Lipid droplet, ER, peroxisome Three predicted TM   Activates fatty acids with a preference for very long chain lengths, C20--C26
  *POX1*                                                      Yes                             Yes                            Acyl-CoA oxidase                                                                                                                           84.0                   8.73                ND                                                      Peroxisomal matrix                                 Oxidation of acyl-CoA
  *CTA1*                                                      No                              Yes                            Catalase                                                                                                                                   58.6                   7.46                623                                                     Peroxisomal matrix                                 Degrades hydrogen peroxide produced by Pox1
  *FOX2 (POX2)*                                               Yes                             Yes                            Multifunctional enzyme; 3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase                                                            98.7                   9.75                ND                                                      Peroxisomal matrix                                 
  *POT1 (FOX3*, *POX3)*                                       Yes                             Yes                            3-Ketoacyl-CoA thiolase                                                                                                                    44.7                   7.56                ND                                                      Peroxisomal matrix                                 Cleaves 3-ketoacyl-CoA into acyl-CoA and acetyl-CoAs
  *DCI1 (ECI2)*                                                                                                              Δ(3,5)-Δ(2,4)-dienoyl-CoA isomerase (putative)                                                                                             30.1                   8.83                ND                                                      Peroxisomal matrix                                 Auxiliary enzyme of fatty acid β-oxidation; role in β-oxidation debated
  *SPS19 (SPX19)*                                             Yes                             Yes                            2,4-Dienoyl-CoA reductase                                                                                                                  31.1                   9.67                ND                                                      Peroxisomal matrix                                 Auxiliary enzyme of fatty acid β-oxidation
  *ECI1*                                                      Yes                             Yes                            Δ3, Δ2-enoyl-CoA isomerase                                                                                                                 31.7                   8.21                ND                                                      Peroxisomal matrix                                 Auxiliary enzyme of fatty acid β-oxidation
  *TES1 (PTE1)*                                               Yes                             Yes                            Acyl-CoA thioesterase                                                                                                                      40.3                   9.58                ND                                                      Peroxisomal matrix                                 Auxiliary enzyme of fatty acid β-oxidation
  *MDH3*                                                      Yes                             Yes                            Malate dehydrogenase                                                                                                                       37.3                   10.00               3,300                                                   Peroxisomal matrix                                 Required for the malate-oxaloacetete shuttle, to exchange peroxisomal NADH for cytosolic NAD^+^, part of the glyoxylate cycle
  *IDP3*                                                      Yes                             Yes                            NADP^+^ dependent isocitrate dehydrogenase                                                                                                 47.91                  10.02               ND                                                      Peroxisomal matrix                                 Required for the 2-ketoglutarate/isocitrate shuttle, exchanging peroxisomal NADP+ for cytosolic NADPH
  *CAT2*                                                      No                              No                             Carnitine acetyl-CoA transferase                                                                                                           77.2                   8.34                470                                                     Peroxisome, mitochondria                           Transfers activated acetyl groups to carnitine to form acetylcarnitine which can be shuttled across membranes
  **Glyoxylate cycle**                                                                                                                                                                                                                                                                                                                                                                                                        
  *CIT2*                                                      No                                                             Citrate synthase                                                                                                                           51.4                   6.34                2,310                                                   Peroxisomal matrix                                 Condensation of acetyl CoA and oxaloacetate to form citrate
  *MDH3*                                                      Yes                             Yes                            Malate dehydrogenase                                                                                                                       37.3                   10.00               3,300                                                   Peroxisomal matrix                                 Required for the malate--oxaloacetete shuttle, to exchange peroxisomal NADH for cytosolic NAD^+^
  *MLS1*                                                      Yes                             Yes                            Malate synthase                                                                                                                            62.8                   7.18                ND                                                      Peroxisomal matrix                                 Required for utilization of nonfermentable carbon sources
  **Other peroxisome-associated enzyme activities**                                                                                                                                                                                                                                                                                                                                                                           
  *GPD1 (DAR1*, *HOR1*, *OSG1*, *OSR5)*                                                                                      NAD-dependent glycerol-3-phosphate dehydrogenase                                                                                           42.9                   5.26                807                                                     Peroxisome, cytosol, nucleus                       Key enzyme of glycerol synthesis, essential for growth under osmotic stress
  *PNC1*                                                                                                                     Nicotinamidase                                                                                                                             25.0                   6.23                7,720                                                   Peroxisome, cytosol                                Converts nicotinamide to nicotinic acid as part of the NAD(+) salvage pathway
  *NPY1*                                                                                                                     NADH diphosphatase                                                                                                                         43.5                   6.26                846                                                     Peroxisome, cytosol                                Hydrolyzes the pyrophosphate linkage in NADH and related nucleotides
  *STR3*                                                                                                                     Cystathionine β-lyase                                                                                                                      51.8                   7.96                ND                                                      Peroxisome                                         Converts cystathionine into homocysteine
  *GTO1*                                                                                                                     ω-Class glutathione transferase                                                                                                            41.3                   9.53                                                                        Peroxisome                                         Induced under oxidative stress
  *AAT2 (ASP5)*                                                                               Yes                            Aspartate aminotransferase                                                                                                                 46.1                   8.50                7,700                                                   Cytosol, peroxisome                                Involved in nitrogen metabolism
  *PCD1*                                                                                                                     Nudix pyrophosphatase with specificity for coenzyme A and CoA derivatives                                                                  39.8                   6.59                238                                                     Peroxisome                                         May function to remove potentially toxic oxidized CoA disulfide from peroxisomes
  *LPX1*                                                                                      Yes                            Triacylglycerol lipase                                                                                                                     43.7                   8.16                2,350                                                   Peroxisomal matrix                                 
  **Peroxisomal transporters**                                                                                                                                                                                                                                                                                                                                                                                                
  *PXA1 (LPI1*, *PAL1*, *PAT2*, *SSH2)*                                                                                      Subunit of a heterodimeric ATP-binding cassette transporter complex                                                                        100.0                  10.34               ND                                                      Peroxisomal membrane                               Import of long-chain fatty acids into peroxisomes
  *PXA2 (PAT1)*                                                                                                              Subunit of a heterodimeric ATP-binding cassette transporter complex                                                                        97.1                   9.47                ND                                                      Peroxisomal membrane                               Import of long-chain fatty acids into peroxisomes
  *ANT1 (YPR128C)*                                                                                                           Adenine nucleotide transporter                                                                                                             36.4                   10.6                2,250                                                   Peroxisomal membrane                               Involved in β-oxidation of medium-chain fatty acids
  **Peroxins**                                                                                                                                                                                                                                                                                                                                                                                                                
  *PEX1 (PAS1)*                                                                                                              AAA ATPase                                                                                                                                 117.3                  6.93                2,100                                                   Peroxisomal membrane                               Involved in recycling of Pex5, forms heterodimer with Pex6
  *PEX2 (CRT1*, *PAS5)*                                                                                                      E3 ubiquitin ligase                                                                                                                        30.8                   9.02                339                                                     Peroxisomal membrane                               RING finger protein, forms complex with Pex10 and Pex12. Involved in matrix protein import
  *PEX3 (PAS3)*                                                                                                                                                                                                                                                         50.7                   6.29                1,400                                                   Peroxisomal membrane                               Required for proper localization of PMPs
  *PEX4 (PAS2*, *UBC10)*                                                                                                     Ubiquitin-conjugating enzyme                                                                                                               21.1                   5.36                ND                                                      Peroxisomal membrane                               Involved in matrix protein import
  *PEX5 (PAS10)*                                                                                                             Soluble PTS1 receptor                                                                                                                      69.3                   4.79                2,070                                                   Cytosol and peroxisomal matrix                     Required for import of PTS1-containing peroxisomal proteins, contains TPR domains
  *PEX6 (PAS8)*                                                                                                              AAA ATPase                                                                                                                                 115.6                  5.44                1,630                                                   Peroxisomal membrane                               Involved in recycling of Pex5, forms heterodimer with Pex1
  *PEX7 (PAS7*, *PEB1)*                                                                                                      Soluble PTS2 receptor                                                                                                                      42.3                   8.34                589                                                     Cytosol and peroxisomal matrix                     Requires Pex18 and Pex21 for association to the receptor docking site, contains WD40 repeat
  *PEX8 (PAS6)*                                                                                                              Intraperoxisomal organizer of the peroxisomal import machinery                                                                             68.2                   7.62                538                                                     Peroxisomal matrix and luminal membrane face       Pex5-cargo dissociation
  *PEX10 (PAS4)*                                                                                                             E3 ubiquitin ligase                                                                                                                        39.1                   9.88                ND                                                      Peroxisomal membrane                               RING finger protein involved in Ubc4-dependent Pex5 ubiquitination. Forms complex with Pex2 and Pex12
  *PEX11 (PMP24*, *PMP27)*                                                                                                                                                                                                                                              26.9                   10.65               1,630                                                   Peroxisomal membrane                               Involved in peroxisome fission, required for medium-chain fatty acid oxidation
  *PEX12 (PAS11)*                                                                                                            E3 ubiquitin ligase                                                                                                                        46.0                   9.86                907                                                                                                        RING finger protein, forms complex with Pex2 and Pex10
  *PEX13 (PAS20)*                                                                                                            Component of docking complex for Pex5 and Pex7                                                                                             42.7                   9.83                7,900                                                   Peroxisomal membrane                               Forms complex with Pex14 and Pex17
  *PEX14*                                                                                                                    Central component of the receptor docking complex                                                                                          38.4                   4.61                2,570                                                   Peroxisomal membrane                               Interacts with Pex13
  *PEX15 (PAS21)*                                                                                                                                                                                                                                                       43.7                   8.42                1,070                                                   Peroxisomal membrane                               Recruits Pex6 to the peroxisomal membrane, tail anchored PMP
  *PEX17 (PAS9)*                                                                                                             Component of docking complex for Pex5 and Pex7                                                                                             23.2                   10.24               656                                                     Peroxisomal membrane                               Forms complex with Pex13 and Pex14
  *PEX18*                                                                                                                    Required for PTS2 import                                                                                                                   32.0                   4.78                ND                                                                                                         Interacts with Pex7; partially redundant with Pex21
  *PEX19 (PAS12)*                                                                                                            Chaperone and import receptor for newly synthesized PMPs                                                                                   38.7                   4.08                5,350                                                   Cytosol, peroxisome; farnesylated                  Interacts with PMPs, involved in PMP sorting. Also interacts with Myo2 and contributes to peroxisome partitioning
  *PEX21*                                                                                                                    Required for PTS2 protein import                                                                                                           33.0                   6.67                ND                                                      Cytosol                                            Interacts with Pex7, partially redundant with Pex18
  *PEX22 (YAF5)*                                                                                                             Required for import of peroxisomal proteins                                                                                                19.9                   8.33                259                                                     Peroxisomal membrane                               Recruits Pex4 to the peroxisomal membrane
  *PEX25*                                                                                                                    Involved in the regulation of peroxisome size and maintenance, required for re-introduction of peroxisomes in peroxisome deficient cells   44.9                   9.77                2,420                                                   Peripheral peroxisomal membrane                    Recruits GTPase Rho1 to peroxisomes, interacts with homologous protein Pex27
  *PEX27*                                                                                                                    Involved in the regulation of peroxisome size and number                                                                                   44.1                   10.49               382                                                     Peripheral peroxisomal membrane                    Interacts with homologous protein Pex25
  *PEX28*                                                                                                                    Involved in the regulation of peroxisome size, number and distribution                                                                     66.1                   7.09                ND                                                      Peroxisomal membrane                               May act upstream of Pex30, Pex31 and Pex32
  *PEX29*                                                                                                                    Involved in the regulation of peroxisome size, number and distribution                                                                     63.5                   6.8                 5,040                                                   Peroxisomal membrane                               May act upstream of Pex30, Pex31 and Pex32
  *PEX30*                                                                                                                    Involved in the regulation of peroxisome number                                                                                            59.5                   5.59                4,570                                                   Peroxisomal membrane                               Negative regulator, partially functionally redundant with Pex31 and Pex32
  *PEX31*                                                                                                                    Involved in the regulation of peroxisome number                                                                                            52.9                   10.15               238                                                     Peroxisomal membrane                               Negative regulator, partially functionally redundant with Pex30 and Pex32
  *PEX32*                                                                                                                    Involved in the regulation of peroxisome number                                                                                            48.6                   9.14                ND                                                      Peroxisomal membrane                               Negative regulator, partially functionally redundant with Pex30 and Pex31
  *PEX34*                                                                                                                    Involved in the regulation of peroxisome number                                                                                            16.6                   10.30               ND                                                      Peroxisomal membrane                               
  **Peroxisome fission and inheritance**                                                                                                                                                                                                                                                                                                                                                                                      
  *DYN2 (SLC1)*                                                                                                              Light chain dynein                                                                                                                         10.4                   9.03                1,310                                                   Cytosol                                            Microtubule motor protein
  *SEC20*                                                                                                                    v-SNARE                                                                                                                                    43.9                   5.92                4,910                                                   Golgi, ER                                          Involved in retrograde transport from the Golgi to the ER; interacts with the Dsl1 complex through Tip20
  *SEC39 (DSL3)*                                                                                                             Component of the Dsl1p-tethering complex                                                                                                   82.4                   4.65                1,840                                                   ER, nuclear envelope                               Proposed to be involved in protein secretion
  *DSL1 (RNS1)*                                                                                                              Component of the ER target site that interacts with coatomer                                                                               88.1                   4.69                8,970                                                   Peripheral ER, Golgi membrane                      Forms a complex with Sec39 and Tip20 that interacts with ER SNAREs Sec20 and Use1
  *FIS1 (MDV2)*                                                                                                              Required for peroxisome fission                                                                                                            17.7                   9.87                2,410                                                   Peroxisomal membrane, mitochondria                 Tail-anchored protein; recruits Dnm1 via Mdv1/Caf4; also involved in mitochondrial fission
  *DNM1*                                                                                                                     GTPase, dynamin-like protein involved in peroxisome fission                                                                                85.0                   5.25                9,620                                                                                                      Also involved in mitochondrial fission
  *VPS1 (GRD1*, *LAM1*, *SPO15*, *VPL1*, *VPT26)*                                                                            GTPase, dynamin-like protein involved in peroxisome fission                                                                                78.7                   8.15                5,960                                                                                                      Also involved in vacuolar protein sorting
  *VPS34 (END12*, *PEP15*, *VPL7*, *VPT29*, *STT8*, *VPS7)*                                                                  Phosphatidylinositol 3-kinase                                                                                                              100.9                  7.79                1,080                                                                                                      Forms complex with Vps15
  *INP1*                                                                                                                     Involved in retention of peroxisomes in mother cells                                                                                       47.3                   8.34                639                                                     Peroxisomal membrane                               Recruited to the peroxisome by binding to Pex3
  *INP2*                                                                                                                     Myo2 receptor, involved in peroxisome inheritance                                                                                          81.5                   9.41                736                                                     Peroxisomal membrane                               
  *RHO1*                                                                                                                     GTP-binding protein of the Rho subfamily of Ras-like proteins; involved in actin assembly at the peroxisome                                23.2                   6.07                ND                                                                                                         Involved in *de novo* peroxisome formation, recruited to peroxisomes by Pex25

Much of the information in the table may be found in the *Saccharomyces* Genome Database. ND, not determined.

[@bib104].

[@bib180]; [@bib145]; [@bib158]; [@bib229]; [@bib362].

The lipid composition of oleate-grown *S. cerevisiae* peroxisomes has been determined by [@bib381]. The peroxisomal membrane contains the major cellular phospholipids---phosphatidylcholine (48.2%), phosphatidylethanolamine (22.9%), and phosphatidylinositol (15.8%)---but also has a remarkably high cardiolipin content (7%). The relative abundance of cardiolipin is noteworthy since this lipid is synthesized in mitochondria ([@bib134]). The other lipids are derived from the ER; however, the mechanisms by which these lipids reach the peroxisomes are not yet firmly established; some evidence suggests that this process involves vesicular transport both from the ER and from mitochondria ([@bib40]).

Peroxisome metabolic functions {#s19}
------------------------------

By definition, peroxisomes contain at least one hydrogen peroxide-producing oxidase together with catalase, which decomposes the hydrogen peroxide by-product of the oxidation reaction. *S. cerevisiae* contains only one oxidase, namely the flavo-enzyme [Pox1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003173) (acyl-CoA oxidase), an enzyme of the β-oxidation pathway. Unlike most other species, *S. cerevisiae* contains a second, cytosolic catalase T, [Ctt1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003320), in addition to the peroxisomal catalase A isoenzyme, [Cta1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002664) ([@bib300]).

The two best-characterized peroxisomal metabolic pathways in *S. cerevisiae* are the β-oxidation of fatty acids ([@bib261]) ([Figure 2B](#fig2){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}) and the glyoxylate cycle ([@bib182]) ([Figure 5](#fig5){ref-type="fig"}). In most other yeast species (*e.g. Candida tropicalis*, *Hansenula polymorpha*, *Pichia pastoris*), several other important peroxisome-bound pathways occur, such as the metabolism of alkanes and methanol and the oxidation of various organic nitrogen sources such as primary amines, purines, and *D*-amino acids (for a review see [@bib336]).

![Compartmentalization of the β-oxidation pathway and the glyoxylate cycle. The enzymes of the β-oxidation (see [Figure 2B](#fig2){ref-type="fig"}) as well as key enzymes of the glyoxylate cycle are localized to peroxisomes in *S. cerevisiae*. In addition to the β-oxidation enzymes, three peroxisomal membrane-associated proteins are required for fatty acid oxidation in peroxisomes, namely the ABC transporter Pxa1/Pxa2 for the import of long-chain acyl-CoA, Faa2 for the activation of medium chain FAs, and the transporter Ant1 for import of ATP. The glyoxylate cycle converts two acetyl-CoA molecules into succinate and contributes to the export of acetyl-CoA that is produced in the β-oxidation cycle. Glyoxylate and the first acetyl-CoA molecule are condensed by malate synthase (Mls) to malate; malate dehydrogenase (Mdh) converts malate to oxaloacetate (OAA); and isocitrate synthase (Cit) condenses OAA and a second acetyl-CoA molecule to form citrate. Aconitase (Aco) catalyzes the isomerization of citrate into isocitrate, which is cleaved by isocitrate lyase (Icl) into succinate and glyoxylate. Glyoxylate can be used for the next round of the glyoxylate cycle, whereas succinate is used to replenish the citric acid cycle or to function as a precursor for amino acid or carbohydrate biosynthesis. In *S. cerevisiae*, citrate synthase, Cit2, and malate synthase Mls1 are peroxisomal enzymes, whereas Icl1 is cytosolic. This is in contrast to plants, filamentous fungi, and other yeast species, in which Icl is peroxisomal as well. Acetyl-CoA can also be exported via the carnitine shuttle, which involves peroxisomal Cat2. The malate shuttle is responsible for NADH export. The predicted small molecule transporters involved in both shuttles or in the glyoxylate cycle have not been identified yet.](1fig5){#fig5}

### β-Oxidation: {#s20}

*S. cerevisiae* can utilize a range of saturated and unsaturated fatty acids of different chain lengths, which, in the absence of glucose, are oxidized by peroxisomal β-oxidation. β-Oxidation involves four steps, namely CoA activation, oxidation, hydratation/dehydrogenation, and thiolytical cleavage to generate acetyl-CoA and an acyl chain that is shortened by two carbon atoms ([Figure 2B](#fig2){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}). Activation of medium chain fatty acids occurs in the organelle matrix via acyl-CoA synthetase, [Faa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000817) ([Figure 5](#fig5){ref-type="fig"}). This process requires ATP, which is imported into the organelle by the adenine nucleotide transporter [Ant1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006332) ([Table 2](#t2){ref-type="table"}) ([@bib252]). It has been suggested that [Faa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000817) produces AMP and pyrophosphate; hence, most likely [Ant1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006332) exchanges AMP for ATP across the peroxisomal membrane. Long-chain fatty acids are activated outside the organelle by [Fat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000245) and taken up as CoA esters via the heterodimeric ABC transporter consisting of [Pxa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006068) and [Pxa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001671) ([@bib135]) ([Figure 5](#fig5){ref-type="fig"}). A portion of the cellular [Fat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000245) activity is associated with peroxisomes ([@bib355]). The acetyl-CoA product of the β-oxidation is transported to mitochondria for further oxidation by the citric acid cycle. Export from peroxisomes occurs via two different pathways, namely via carnitine-dependent acetyl-CoA transport that involves [Cat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004506) or via the glyoxylate cycle ([Figure 5](#fig5){ref-type="fig"}). NADH is transferred to the cytosol via the malate shuttle ([Figure 5](#fig5){ref-type="fig"}) (for an excellent review see [@bib342]).

For β-oxidation of unsaturated fatty acids with *trans* and *cis* double bonds at odd-numbered positions or *cis* double bonds at even positions, auxiliary peroxisomal enzymes are required, *i.e.*, [Eci1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004274), [Dci1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005706), [Tes1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003780), and [Sps19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005146) ([@bib342]) ([Table 2](#t2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). For example, oleic acid metabolism requires the auxiliary enzyme [Eci1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004274), which catalyzes the isomerization of the *cis* double bond of oleate after shortening of the oleoyl-CoA chain by three rounds of β-oxidation ([@bib181]). [Eci1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004274) also isomerizes a fraction of 2-*trans*, 5-*cis*-tetradecadienoyl-CoA, an intermediate of oleic acid β-oxidation, to 3,5-*cis*-tetradecadienoyl-CoA, which has two conjugated double bonds that prevent further β-oxidation. [@bib121] proposed that 3,5-*cis*-tetradecadienoyl-CoA is oxidized by the reductase-dependent pathway and involves the dienoyl isomerase [Dci1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005706). However, recent data also indicate that the thioesterase-dependent pathway, which involves the acyl-CoA thioesterase [Tes1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003780), is operative in *S. cerevisiae* ([@bib234]).

The β-oxidation of unsaturated fatty acids with a double bond at an even position requires the function of the NADPH−dependent 2,4-dienoyl-CoA reductase [Sps19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005146). The NADP^+^ generated by this reaction is reduced by the peroxisomal isocitrate dehydrogenase [Idp3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004954), and, for the regeneration of NADPH, an isocitrate/2-oxoglutarate shuttle exists (reviewed in [@bib342]).

The role of [Pcs60](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426)/[Fat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426), which is associated with the inside of the peroxisomal membrane, is still unclear. [Pcs60](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426)/[Fat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426) belongs to the family of proteins that act via an ATP-dependent covalent binding of AMP to their substratesand shows high similarity to *Escherichia coli* long-chain acyl-CoA synthetases ([@bib33]). However, [Pcs60](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426)/[Fat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000426) is not required for growth of *S. cerevisiae* on oleate. Interestingly, this protein binds mRNAs encoding proteins involved in triglyceride metabolism ([@bib332]).

### Glyoxylate cycle: {#s21}

The glyoxylate cycle allows cells to convert two acetyl-CoA molecules into succinate, which can be used to replenish the citric acid cycle or to function as precursors for amino acid or carbohydrate biosynthesis ([Figure 5](#fig5){ref-type="fig"}). In yeast, this cycle is essential for growth on oleate or C2 substrates such as ethanol or acetate. In *S. cerevisiae*, three glyoxylate cycle enzymes are cytosolic, namely the malate dehydrogenase [Mdh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005486), the aconitase [Aco1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004295), and the isocitrate lyase [Icl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000867), whereas two are peroxisomal: namely citrate synthase [Cit2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000598) and malate synthase [Mls1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005061) ([@bib213]; [@bib322]) ([Figure 5](#fig5){ref-type="fig"}). Remarkably, in most other yeast species, in plants, and in filamentous fungi, isocitrate lyase also is a peroxisomal enzyme (for a review see [@bib182]). The presence of [Icl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000867) in the cytosol of *S. cerevisiae* is surprising as it catalyzes the production of the reactive compound glyoxylate. Thus, the compartmentalization of the enzymes of the glyoxylate cycle predicts the presence of solute transporters for glyoxylate cycle intermediates in the peroxisomal membrane ([Figure 5](#fig5){ref-type="fig"}). It is, however, also possible that no specific transport proteins are required since yeast peroxisomal membranes contain pore-forming proteins that allow passage of small molecules with a molecular mass up to 400 Da, which is sufficient to allow passage of these intermediates ([@bib14]). However, the genes encoding these pore-forming proteins have not yet been identified.

### Other peroxisomal enzymes: {#s22}

Except for the key enzymes involved in fatty acid utilization and the glyoxylate cycle, additional enzymes are (perhaps only transiently) associated with peroxisomes in *S. cerevisiae*. However, for many of these proteins the physiological relevance is unclear ([Table 2](#t2){ref-type="table"}). Moreover, in some cases their peroxisomal localization has not yet been firmly established. Some examples are detailed below. [Lpx1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005610) is a peroxisomal protein that has acyl hydrolase and phospholipase A activity *in vitro*. Deletion of *[LPX1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005610)* results in peroxisomes with aberrant morphology that is characterized by intraperoxisomal vesicles or invaginations, which may point to a role of vesicle fusions in peroxisome development ([@bib326]). Several peroxisomal matrix proteins have been implicated to play a role in (oxidative) stress response or aging. Glycerol-3-phosphate dehydrogenase 1 ([Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180)) is a key enzyme in glycerol biosynthesis and essential for *S. cerevisiae* to cope with osmotic stress ([@bib10]); its expression is regulated by the high-osmolarity glycerol response pathway. Fluorescence microscopy ([@bib145]) and proteomics analysis of peroxisomal fractions ([@bib205]) indicated a (partial) peroxisomal localization of [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180). This was recently confirmed by [@bib152] who showed that [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180) is targeted to peroxisomes via the PTS2 pathway (see below). However, under stress conditions, [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180) is localized to the cytosol and the nucleus, a process that is regulated by phosphorylation of a residue adjacent to the PTS2 in [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180). The physiological relevance of the different subcellular locations remains to be established.

Interestingly, [Pnc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005), whose import into peroxisomes also depends on the PTS2 pathway, shows a similar shift in localization in response to stress ([@bib12]). Moreover, the expression of *[GPD1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180)* and *[PNC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005)* is strongly correlated ([@bib152]). [Pnc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005) converts nicotinamide to nicotinic acid as part of the NAD^+^ salvage pathway. Nicotinamide strongly inhibits [Sir2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002200), a protein important for life-span extension by calorie restriction ([@bib154]), and, like [Sir2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002200), [Pnc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005) also functions in life-span extension ([@bib12]). Most likely, [Pnc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005) regulates longevity by reducing nicotinamide levels, which activates [Sir2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002200) ([@bib96]). Whether the localization of [Pnc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003005) to peroxisomes is important for its function in life-span extension is not yet known.

*[GTO1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003386)* encodes a PTS1 containing ω-class peroxisomal glutathione transferase ([@bib25]), whose expression is induced by oxidative stress. The role of [Gto1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003386) may be related to the redox regulation of cystathionine β-lyase, [Str3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003152), another putative peroxisomal protein ([@bib286]; [@bib369]). [Str3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003152) is involved in transulfuration of cysteine to homocysteine ([Table 2](#t2){ref-type="table"}).

Finally, two phosphatases, [Npy1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003035) and [Pcd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004141), were found to be localized to peroxisomes. [Npy1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003035) is a PTS1-containing diphosphatase, which utilizes NADH as its preferred substrate. This enzyme may function in the regulation of nicotinamide coenzyme concentrations or in the elimination of oxidized nucleotide derivatives ([@bib1]). [Pcd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004141) is a PTS2-containing diphosphatase, which is active toward coenzyme A and its derivatives ([@bib51]). A proposed role for this enzyme is the removal of potentially toxic oxidized CoA disulfide in peroxisomes ([@bib51]).

Methods to identify proteins involved in peroxisome biology {#s23}
-----------------------------------------------------------

### Identification of peroxisomal enzymes: {#s24}

Peroxisome-borne proteins were first identified by biochemical analysis of fractions enriched in peroxisomes obtained by subcellular fractionation. This approach became feasible because of the pioneering work of the Nobel Laureate Christian de Duve, who was the first to isolate peroxisomes from rat liver ([@bib67]). However, it took a decade before the first report appeared on the isolation of *S. cerevisiae* peroxisomes from derepressed cells ([@bib253]), and controversies regarding the yeast peroxisomal protein content remained over several years. Major improvements in the preparation techniques were achieved after the finding that peroxisome proliferation in *S. cerevisiae* can be induced by oleate ([@bib344]). Together with the optimization of cell fractionation protocols for *S. cerevisiae*, [@bib213] were able to convincingly show the localization of enzymes of the glyoxylate and β-oxidation in highly purified peroxisomal fractions of oleate-grown yeast. Today, these procedures are classic in peroxisome research and still in use (among others) to determine the organelle proteome and to characterize defects in peroxisome assembly in mutant strains (for detailed protocols see [@bib74]).

### Discovery of peroxins by genetic approaches: {#s25}

Growth of *S. cerevisiae* on oleate requires intact peroxisomes; hence peroxisome-deficient mutants were readily selected from collections of oleate utilization-deficient mutants ([@bib80]). The corresponding *PEX* genes were cloned by functional complementation upon transformation of the selected mutant with a genomic library. In this way, the first *PEX* gene was identified in baker's yeast ([@bib81]). Subsequently, similar approaches were used for other yeast species, including *Yarrowia lipolytica* and *Pichia pastoris*, two yeast species that are also capable of growing on oleate, as well as *Hansenula polymorpha*, which, like *P. pastoris*, can grow on methanol as the sole source of carbon and energy ([@bib337]; [@bib201]; [@bib235]). In these latter two species, *H. polymorpha* and *P. pastoris*, peroxisomes are essential for growth on methanol, a property used for the identification of *PEX* genes. The identification of novel *PEX* genes in the other yeast species facilitated the work in *S. cerevisiae* because homologous genes were readily cloned on the basis of sequence homology, especially after completion of the sequencing of the entire *S. cerevisiae* genome ([@bib107]). This was particularly advantageous because of the functional redundancy of some *S. cerevisiae PEX* genes and the lack of clear phenotypes of certain *pex* mutants.

Most of the *S. cerevisiae PEX* genes identified by the above approaches appear to be involved in matrix protein import---namely *[PEX1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680)*, *-2*, *-4*, *-5*, *-6*, *-7*, *-8*, *-10*, *-12*, *-13*, *-14*, *-15*, *-17*, *-18*, *-21*, *-22* ([Table 2](#t2){ref-type="table"})---whereas two genes, *[PEX3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* and *[PEX19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)*, are proposed to be essential for the formation of functional peroxisomal membranes. In the first group of mutants, remnant peroxisomal membrane structures (also termed "ghosts") are still present, indicating that the formation of peroxisomal membranes is independent of the matrix protein import process. In *[pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* and *[pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* mutants, however, peroxisome membrane structures are not detectable. In both groups of mutants, most of the peroxisomal matrix proteins are mislocalized to the cytosol, where they are relatively stable. PMPs are also stable in mutants of the first group and localize to the peroxisomal ghosts. In *[pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* or *[pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* mutants, however, PMPs are mislocalized to the cytosol or the ER, or are rapidly degraded ([@bib136]; [@bib245]).

Most of the recently identified *PEX* genes ([Table 2](#t2){ref-type="table"}) have been identified by alternative approaches (see section below). In general, deletion of these genes results in alterations of peroxisome numbers and/or size and is not accompanied by mislocalization of peroxisomal protein or major defects in growth on oleate media.

As shown in [Table 2](#t2){ref-type="table"}, not all *PEX* genes that have been identified so far are also present in *S. cerevisiae*. *PEX9* was solely identified in the yeast *Y. lipolytica*, but later studies revealed that it was incorrectly annotated and in fact encodes *PEX26* ([@bib163]). *PEX16* occurs only in higher eukaryotes and in filamentous fungi, but is absent from most yeast species, with the exception of *Y. lipolytica* ([@bib163]). *PEX20* encodes a peroxin in filamentous fungi, which is the functional ortholog of *S. cerevisiae* [Pex18](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001203) and the partially redundant protein [Pex21](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003471), coreceptors in the PTS2 matrix protein import pathway (for details see below). Similarly, Pex26 occurs only in higher eukaryotes and filamentous fungi, but can be regarded as the functional homolog of *S. cerevisiae* [Pex15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005404), which is a PMP that recruits the two ATPases and members of the AAA-protein family, [Pex1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680) and [Pex6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005273), to the peroxisomal membrane.

Pex33 was identified in the filamentous fungus *Neurospora crassa* and shows homology to a short N-terminal domain of [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) ([@bib203]). A similar protein was identified in the fungus *Penicillium chrysogenum*, where it was designated [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121)/17 ([@bib242]).

*Y. lipolytica Pex23* has three homologs in *S. cerevisiae* that are designated [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372) in this organism; *Y. lipolytica* Pex24 is homologous to *S. cerevisiae* [Pex28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193) and [Pex29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887) ([Table 2](#t2){ref-type="table"}).

### Identification of peroxisomal proteins by organelle proteomics: {#s26}

*[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)* is the first peroxin that has not been cloned by classic genetic approaches. Instead, it was identified by sequencing of a protein present in purified peroxisomal membranes followed by reversed genetics ([@bib79]; [@bib207]). The same approach resulted in the identification of other novel PMPs, such as Psc60, [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181), and [Ant1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006332). The first mass spectrometry analyses of purified peroxisomal membrane fractions were reported in 2001 ([@bib286]) and in 2002 ([@bib369]) and resulted in the identification of several novel candidate peroxisomal proteins. An extensive analysis of the proteome of isolated *S. cerevisiae* peroxisomes was reported by [@bib205]. In this study, classic subcellular fractionation procedures were combined with immuno-isolation to obtain fractions enriched in peroxisomes from oleate-grown cells. This quantitative proteomics study resulted in a list of 71 candidate proteins that had a high likelihood of being peroxisomal because 28 of them were already annotated as being peroxisomal. Interestingly, the list contained several candidate proteins that were previously localized to other cell compartments, such as the LD protein [Faa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005844) and six proteins linked to the secretory pathway, namely [Dpm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006387), [Ybr159w](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000363), [Yor086c](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005612), [Ygr266w](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003498), [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369), and [Cdc42](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004219). Biochemical and microscopic studies of a selection of eight of the candidate proteins confirmed that most of these proteins were, at least transiently, located to peroxisomes such as [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369), [Emp24](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003168), [Faa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005844), and [Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467) ([@bib205]).

[Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369) is a small GTPase typically localizing to the plasma membranes and endomembranes in glucose-grown cells. However, [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369) also localizes to the peroxisomal surface where it is recruited by the PMP [Pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033) ([@bib205]); it is suggested that it regulates the assembly state of [actin](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855) and thereby controls peroxisome membrane dynamics. Recent data in *H. polymorpha* revealed that in that yeast species a significant portion of Rho1 also colocalizes with peroxisomes ([@bib284]); Rho1 as well as Pex25 are essential for the generation of peroxisomes in *H. polymorpha pex3* cells upon transformation and expression of *PEX3* (for details see below).

The role of *S. cerevisiae* [Emp24](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003168) in peroxisome biology has not yet been analyzed in greater detail. [Emp24](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003168) is a member of the family of p24 proteins, which are membrane proteins that are abundantly present in the membranes of the early secretory pathway (for a review see [@bib314]). Studies in *H. polymorpha* showed that a (minor) portion of *H. polymorpha* Emp24 colocalizes to peroxisomes, where it is important for peroxisome fission by an as-yet-unknown mechanism ([@bib186]).

[Erg6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004467) and [Faa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005844) are typically localized to the ER and LDs (see above; [Table 1](#t1){ref-type="table"}), but were also found to colocalize with peroxisomes, which may reflect the close physical and physiological interaction between these organelles. Alternatively, however, the peroxisomal fractions analyzed may have been contaminated with LDs, which are also induced in the presence of oleate ([@bib30]; [@bib264]). A large number of candidate peroxisomal proteins identified in the study by [@bib205] have not yet been further analyzed, but are of high interest for future peroxisome research.

### In silico prediction of peroxisomal proteins: {#s27}

Comparative genomics approaches have been used to identify putative peroxisomal matrix proteins based on consensus sequences of the *p*eroxisomal *t*argeting *s*ignals (PTSs) PTS1 and PTS2. The first report on *in silico* prediction of *S. cerevisiae* peroxisomal matrix proteins was by [@bib156]. [@bib78] designed an improved predictor (PeroxiP, [http:www.bioinfo.se/PeroxiP/](http://www.bioinfo.se/PeroxiP/)) in which the sequence of the nine amino acids that immediately precede the PTS1 consensus sequence also was included as a criterion. Another predictor specific for PTS1 proteins has been generated by [@bib230],[@bib231]; mendel.imp.ac.at/mendeljsp/ sat/pts1/PTS1predictor.jsp). Although very successful for metazoans and plants, these methods have not been very effective in identifying novel peroxisomal yeast proteins.

The limited success of using peroxisomal targeting sequences for the prediction of yeast peroxisomal proteins may be due to the fact that several peroxisomal matrix proteins exist that lack a consensus PTS, *e.g.*, [Pox1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003173) and [Cat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004506) ([@bib335]). On the other hand, proteins that do have a PTS based on computer predictions may not be peroxisomal because these signals are masked by protein conformation or altered/removed by post-translational processes. Moreover, it was recently established that in certain fungi some glycolytic enzymes obtain a PTS only upon ribosomal readthrough or by differential splicing, resulting in partial peroxisomal localization of these predominantly cytosolic enzymes ([@bib94]). In addition, *in silico* prediction is not yet possible for PMPs because no specific signature is currently known for these proteins.

### Transcriptome analysis: {#s28}

Another approach that has been used to identify peroxisomal proteins is the analysis of transcripts that are induced upon stimulation of peroxisome proliferation. Serial Analysis of Gene Expression analysis ([@bib155]) revealed that predominantly genes encoding peroxisomal enzymes of the β-oxidation pathway and other proteins participating in oleate metabolism were upregulated upon shifting *S. cerevisiae* from glucose to oleate media. This study resulted in the first identification of the acyl-CoA thioesterase [Tes1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003780). The rather surprising outcome of this study was that, with the exception of *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)*, the messenger RNA levels of *PEX* genes remained unaltered after the shift from glucose to oleate medium ([@bib155]).

[@bib301] were the first to perform microarray analysis to identify novel oleate-inducible peroxisomal proteins. In this study, candidate genes were identified by pattern matching of profiles of genes known to be involved in peroxisome biogenesis or function by using three complementary clustering algorithms. Thus, in addition to highly induced genes, genes that have lower levels of induction but similar induction patterns were identified. The screen resulted in a list of 225 candidate genes of which 2 were further analyzed to validate the approach. Indeed, both genes, *[LPX1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005610)* and *[PEX25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033)* ([Table 2](#t2){ref-type="table"}), encoded novel peroxisomal proteins. Microarray studies using the methylotrophic yeast *H. polymorpha* also showed that predominantly the peroxisomal enzymes of methanol metabolism are strongly induced upon a shift of cells from glucose to methanol medium ([@bib343]). Again, *PEX* genes were not or were only slightly induced under these conditions; the highest increase in gene expression (four- to fivefold) was observed for *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)* and *[PEX32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372)* upon induction of peroxisome proliferation.

### Microscopic analysis of peroxisomes: {#s29}

A direct way to identify peroxisomal proteins is by fluorescence microscopy. Today several genome-wide studies to localize the entire *S. cerevisiae* proteome have been reported. The first study was performed by [@bib180] who used indirect, high-throughput immunofluorescence. These authors epitope-tagged 2085 *S. cerevisiae* ORFs and also randomly tagged genes by transposon mutagenesis. However, novel peroxisomal proteins were not identified by this approach.

In 2003, Huh *et al.* performed fluorescence microscopy of glucose-grown cells of an *S. cerevisiae* collection of strains that express C-terminal GFP fusion proteins. This study resulted in 21 proteins with a putative peroxisomal localization. This rather low number may be related to the fact that the proteins were C-terminally tagged, which masks the function of the C-terminal PTS1 sequences. Moreover, cells were grown on glucose in this study, and thus peroxisome proliferation was not strongly induced ([@bib145]). This study, however, resulted in the detection of novel peroxisomal proteins and showed the association of [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180) with peroxisomes ([Table 1](#t1){ref-type="table"}). Natter and colleagues ([@bib158]; [@bib229]) carried out a similar study with plasmid-encoded C-terminal GFP fusion proteins. This study by Natter *et al*. was limited to 493 proteins, which were selected on the basis of their potential participation in lipid metabolism and membrane assembly; the localization of 16 known yeast peroxisomal proteins was also confirmed by that study.

[@bib362] used GFP fused to a PTS1 under the control of the *[ADH1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005446)* promoter to analyze all 4740 viable yeast deletion strains by confocal imaging and automated quantitative analysis for peroxisome deficiency or morphological alterations. In addition to all previously known *pex* mutants defective in PTS1 protein import, *[mdh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005486)* and *[afg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000778)* deletion mutants showed a significant amount of cytosolic GFP-PTS1 as well. *[MDH2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005486)* encodes a cytosolic malate dehydrogenase, whose function is important in peroxisomal β-oxidation ([Figure 5](#fig5){ref-type="fig"}). *[AFG1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000778)* encodes a mitochondrial member of the AAA family of proteins. Analysis of the localization of additional peroxisomal membrane and matrix markers in *[mdh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005486)* and *[afg1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000778)* cells indicated that both strains are defective in PTS1 and PTS2 matrix protein import, but not in the formation of peroxisomal membranes. How these proteins specifically function in matrix protein import is not yet known.

[@bib278] analyzed a collection of 249 mutant strains lacking nonessential kinases, phosphatases and cyclins for alterations in peroxisome biology. In this study, GFP was fused to the C terminus of the PTS2 protein [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422). The *[POT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)* promoter contains an oleate-responsive element, which is typical for oleate-induced peroxisomal β-oxidation enzymes (for a review see [@bib120]). Cells were analyzed using a combination of confocal laser scanning microscopy to monitor peroxisome abundance and morphology and fluorescence activated cell sorting (FACS) to measure [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)-GFP fluorescence levels. Different classes of regulatory proteins were found to regulate *[POT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)* expression and peroxisome number and size; interestingly, the nonessential cyclin-dependent kinase [Pho85](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005952) was shown to be involved in both. Prominent effectors in peroxisome biogenesis identified in that study include [actin](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)-regulating proteins, which function through the action of Rho regulators (*e.g.*, [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369)), as well as proteins involved in phosphatidylinositol metabolism (*e.g.*, [Vps34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004230)). The latter group of proteins may mediate so far unknown membrane fusion processes in peroxisome biogenesis ([@bib278]). In a recent update to this study, [@bib279] analyzed some 4000 *S. cerevisiae* deletion strains expressing chromosomally integrated [Pox1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003173)-GFP. In this screen, most of the known *PEX* genes required for PTS2 protein import were identified. In addition, deletion of *[CBS1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002227)* resulted in mislocalization of [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)-GFP. This was a very unexpected finding because [Cbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002227) is a mitochondrial translational activator. Interestingly, [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)-GFP import into peroxisomes partially recovered when *[cbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002227)* cells were maintained for several days on solid growth media. In addition, the screen revealed three novel proteins involved in peroxisome inheritance: [Vps52](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002892), a regulator of [actin](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855); [Pir3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001646), involved in cell-wall organization; and [Ykr015c](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001723), a protein of unknown function. Several additional mutants that displayed alterations in peroxisome size and/or number were identified (see the Yeast Peroxisome Cellular Imaging Resource at <http://pbeid.systemsbiology.net>). These include the known genes involved in the regulation of peroxisome size, *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)*, *[VPS1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709)*, and *[DNM1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924)*, as well as two novel genes, *[MNN11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003719)*, encoding a subunit of a Golgi-resident mannosyltransferase, and *[HSL7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000337)*, encoding the bud-neck-localized protein arginine *N*-methyltransferase. The role of these proteins in regulating peroxisome proliferation still needs to be established.

Many of the proteins identified in the various imaging-based screens do not localize to peroxisomes or are rather known to be involved in other cellular processes. Deletion of genes encoding mitochondrial proteins leads to a reduction in peroxisome numbers, *e.g.*, [Cox6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001093), [Cox9](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002225), and [Cox10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006093), which are involved in mitochondrial respiration, further stressing the functional and metabolic links between peroxisomes and mitochondria. Indeed, defects in mitochondrial function have previously been indicated to stimulate peroxisome proliferation---the so-called retrograde response. Also, deletion of two genes encoding vacuolar proteins results in reduced numbers of peroxisomes, *i.e.*, the vacuolar t-SNARE [Vam3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005632) or the subunit of the vacuolar ATPase [Vph1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005796). Similarly, deletion of the *VAM3* and *VAM7* genes encoding two vacuolar t-SNARES in *H. polymorpha* also results in unusual peroxisomal structures with multiple membrane-enclosed compartments ([@bib313]).

Surprisingly, given the important proposed role for the ER in peroxisome biogenesis (see below), no ER proteins were identified in the screen of [@bib279] that were important for peroxisome biogenesis, inheritance, or regulation of organelle number. Only deletion of *[FEN1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000630)*, a gene required for fatty acid elongation ([@bib134]), showed an effect on peroxisome size and resulted in enlarged organelles ([@bib279]).

Peroxisome Biogenesis {#s30}
=====================

Peroxisomal matrix protein import {#s31}
---------------------------------

### Targeting signals and their receptors: {#s32}

The peroxisomal matrix protein import machinery has unique properties and differs fundamentally from import systems of other eukaryotic organelles in that it can translocate *folded* proteins and even protein complexes across the membrane. Peroxisomal matrix proteins are nuclear encoded, synthesized in the cytosol, and subsequently post-translationally imported into the organelle. These proteins harbor PTSs that are recognized by the soluble receptor proteins [Pex5p](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) (PTS1) and [Pex7p](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) (PTS2), respectively. It is generally assumed that PTS1 signals are not cleaved upon import, whereas a few PTS2 sequences were indeed shown to be processed upon import in higher eukaryotes.

### PTS1 and its receptor Pex5: {#s33}

The first PTS1 that has been described is the C-terminal tripeptide SKL in firefly luciferase ([@bib112]). This PTS1 tripeptide, as well as the PTS1 peroxisomal import machinery, is highly conserved in yeast, plants, insects, and mammals ([@bib113]). Detailed sequence analysis and mutagenesis studies revealed that the PTS1 tripeptide invariably consists of a small neutral amino acid at the first position, followed by an amino acid residue capable of hydrogen bonding at the penultimate position and a hydrophobic residue at the extreme C terminus. Also, the tripeptide must be present at the extreme C terminus of the protein. The most commonly used consensus of the PTS1 tripeptide is \[(S/A/C)(K/R/H)(L/M)\]. Studies by [@bib189] have suggested a broader degeneracy in yeast and human PTS1 sequences. Also, not all PTS1 peptides that bind human [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) can bind yeast [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) as well, demonstrating some species specificity.

Detailed studies on the interaction of the PTS1-binding domain of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) with various proteins/peptides indicate that residues upstream of the PTS1 tripeptide also are important for cargo recognition. Therefore, the PTS1 is now defined as a C-terminal 12-amino-acid sequence, which consists of the C-terminal tripeptide that interacts with the PTS1-binding site in [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), a tetrapeptide immediately upstream of this tripeptide, which may interact with the surface of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), and a flexible hinge region of five residues (reviewed by [@bib42]).

The PTS1 receptor [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) consists of a relatively poorly conserved N-terminal domain and a C-terminal domain, which contains six tetratricopeptide repeats (TPR). A typical feature of the N terminus of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) is the presence of several WxxxF/Y motifs. In human [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), these motifs are required for binding of the receptor to [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) and [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121), but in yeast the WxxxF/Y motif is important only for [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) binding ([@bib358]). The N terminus of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) also is the region where the protein is modified by mono- or multiubiquitination, which is important for receptor recycling (see below).

The [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) TPR domain is the actual PTS1-binding site ([@bib43]). According to a crystal structure of the TPR domain of human Pex5, the PTS1 is locked in a groove allowing various interactions with two sets of three TPR motifs linked together by a helical hinge ([@bib102]). Structural studies by [@bib309] using the human [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) TPR domain and a full-length peroxisomal matrix protein, the sterol carrier protein 2 (SCP2), indicated that the cargo is bound to the receptor by two separate binding sites: a C-terminal PTS1 motif and a topologically separated secondary site. These studies also revealed major conformational changes of the receptor that occur upon cargo loading. Unfortunately, so far no structural data on a full-length [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) protein have been reported. For further details on the structural properties of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), the reader is referred to the excellent review by [@bib310].

As discussed above for the SCP2 protein, the PTS1-binding site in the C-terminal TPR domain of the [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) receptor is not the only site of interaction with cargo. Some matrix proteins without ([@bib165]) or with a redundant PTS1 ([@bib118]) also bind to the N terminus of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), such as [Pox1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003173) and [Cat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004506) in *S. cerevisiae* ([@bib285]) and alcohol oxidase in *H. polymorpha* ([@bib118]). Mutational analysis of the *S. cerevisiae* [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) N terminus indicates that the domains that are required for [Cat2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004506) and [Pox1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003173) binding are overlapping but not identical. Hence, most likely multiple residues in the N terminus of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) are involved in the recognition of non-PTS1 proteins.

The occurrence of different matrix protein-binding sites in [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) variants was nicely illustrated by studies of [@bib250], who showed that *S. cerevisiae* [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) (via its TPR domain) and *H. polymorpha* Pex5 (via its N-terminal domain) recognize different, independent binding sites in the same peroxisomal matrix protein. Also, *S. cerevisiae* peroxisomal catalase A has a redundant PTS1, which is the very unusual hexapeptide SSNSKF. Catalase A has a second internal PTS, but it is unknown to which region (N or C terminus) of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) this sequence actually binds ([@bib176]).

### PTS2 and Pex7 with its coreceptors: {#s34}

PTS2 was first identified in rat liver thiolase, where it is present as an N-terminal presequence that is processed upon import. Only a few proteins have a PTS2 for which the consensus sequence is (R/K)(L/V/I)*X*~5~(Q/H)(L/A/I). *S. cerevisiae* expresses only three peroxisomal proteins with a firmly established PTS2, namely [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422), [Pcd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004141), and [Gpd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002180).

The PTS2 is recognized by the soluble receptor [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549), which is characterized by the presence of six WD repeats. On the basis of its sequence, the receptor is predicted to fold as a seven-bladed β-propeller domain, in which each "blade" comprises a so-called WD repeat ([@bib198]; [@bib310]); however, no [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) crystal structures have been resolved yet.

[Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) requires additional proteins that function as coreceptors. In *S. cerevisiae*, these are the partially redundant, homologous proteins [Pex18](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001203) and [Pex21](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003471) (for a review see [@bib291]). In other yeast species and filamentous fungi, this function is fulfilled by Pex20 ([@bib76]). The coreceptors share a characteristic N-terminal region that contains WxxxF/Y sequence motifs, such as the N terminus of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) and a [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549)-binding region. Also, like the [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) N terminus, these proteins are ubiquitinated, a process that is required for recycling of the proteins ([@bib197]). Additional functions have also been attributed to the coreceptor proteins, *e.g.*, in oligomerization of the cargo protein ([@bib328]) or in PTS2 binding ([@bib246]).

### Piggy-back import: {#s35}

Some peroxisomal proteins without a recognizable PTS still can be imported into peroxisomes in complex with a PTS-containing protein. Recently, the first example of piggy-back import was reported for the mammalian peroxisomal protein, superoxide dismutase ([@bib146]). The examples that have been reported in yeast ([@bib106]; [@bib214]) all comprise artificial co-expression of oligomeric proteins with and without PTS sequences, and it is currently unclear whether piggy-back import indeed occurs for endogenous yeast proteins *in vivo*.

### Receptor docking site: {#s36}

The receptor-cargo complex docks at the outer surface of the peroxisomal membrane to a proteinaceous receptor docking site that consists of the three peroxisomal membrane proteins [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181), [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121), and [Pex17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005158). [Pex17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005158), which interacts with [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121), occurs only in *S.cerevisiae*, and its function is still enigmatic. [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) and [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) are highly conserved, and they interact with each other as well as with both [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) and [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) import receptors ([Figure 6A](#fig6){ref-type="fig"}). [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) is an integral membrane protein that contains two transmembrane regions and a Src homology 3 (SH3) domain at the extreme C terminus, which is exposed to the cytosol. The extreme N terminus of [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) binds [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) ([@bib311]), whereas the SH3 domain has distinct binding sites for [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) and [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) ([@bib259]). In [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121), a PxxP domain, as well as other conserved residues, is involved in the interaction with the [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) SH3 domain ([@bib105]; [@bib35]). [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) also binds to a region in between the two transmembrane domains of [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) ([@bib289]). In addition, indirect interactions may occur between both peroxins, which could explain why disruption of individual interaction sites often does not significantly affect protein import *in vivo* ([@bib357]).

![Peroxisomal protein import. (A) Hypothetical model of PTS1 protein import. First, cytosolic Pex5 binds a newly synthesized PTS1-containing cargo protein ("cargo"). The PTS1 binds to the C-terminal TPR domain of Pex5. Next, Pex5 docks to the receptor-docking complex at the peroxisomal membrane, which is composed of Pex13, Pex14, and Pex17. Docking involves the N-terminal domain of Pex5, indicated as a spiral. Subsequently, the Pex5-cargo complex is imported into the organellar matrix. Pex5 most likely forms a transient pore in the peroxisomal membrane. The Pex5-cargo complex than dissociates in a process that involves Pex8, a peripheral membrane protein in the peroxisomal matrix. Finally, Pex5 is recycled back to the cytosol, a process that enables it to bind the next PTS1 cargo protein. Recycling involves mono-ubiquitination of Pex5 by the UBC protein Pex4, which is recruited to the peroxisomal membrane by Pex22. The three RING finger proteins Pex2, Pex10, and Pex12 are proposed to serve as E3 ligases. The ubiquitinated Pex5 is pulled out of the membrane by the AAA proteins Pex1 and Pex6, which are associated with the peroxisomal membrane via Pex15. When Pex5 recycling fails, it becomes polyubiquitinated by Ubc4/5 and degraded by the proteasome. (B) Hypothetical model of PTS2 protein import. Dimeric Pot1 is shown as an example of a typical PTS2 protein. Dimeric Pot1 first binds to the PTS2 receptor Pex7. Subsequently, the coreceptor Pex18 (and possibly also Pex21) binds to the receptor/cargo complex. Pex7 associates with Pex13 of the docking complex. After import of the Pot1 cargo into peroxisomes by an as-yet-unknown mechanism Pex7 recycles back to the cytosol. Pex18, however, first forms a complex with Pex14. Whether and how Pex18 recycles for another round of import is unknown.](1fig6){#fig6}

Although [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) can directly interact with [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652), [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) is most likely the initial docking protein in the peroxisomal membrane in the course of PTS1 protein import ([@bib334]); [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) may have a similar function in docking of [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549). Recently, [@bib117] showed that the PTS2 protein [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422) first binds [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) in a process that is independent of the coreceptors [Pex18](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001203) and [Pex21](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003471). Next, a cytosolic [Pot1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001422)-[Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549)-[Pex18](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001203) complex that docks to the peroxisomal membrane via the interaction between [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) and [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) is formed. It was proposed that [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) and the cargo dissociate during or after assembly of a large complex with [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) and [Pex13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004181) (for details see [Figure 6B](#fig6){ref-type="fig"}).

The first *[PEX14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121)* gene was cloned in *H. polymorpha* by functional complementation of a mutant defective in growth on methanol ([@bib175]). The *S. cerevisiae* homolog was cloned by the Kunau group, based on the sequence homology with *H. polymorpha PEX14*, and was shown to represent the [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) docking site ([@bib9]). At the same time, [@bib44] isolated the yeast homolog by a two-hybrid screen using [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) as a bait. [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) is characterized by a coiled-coil region in the middle part of the protein that is involved in homo-dimerization; however, its topology in the membrane is still debated ([@bib24]).

The conserved extreme N-terminal region adopts an α-helical structure ([@bib71]). The N terminus of *S. cerevisiae* [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) has been implicated in [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) binding, whereas its C terminus contains overlapping [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652)- and [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549)-binding sites ([@bib233]; [@bib358]). In *H. polymorpha*, however, no receptor binding sites have been identified in the Pex14 C terminus ([@bib28]); instead, in *H. polymorpha* the Pex14 N terminus most likely binds both Pex5 and Pex7, as it is involved in both PTS1 and PTS2 protein import ([@bib71]). Structural studies using purified proteins showed that the N terminus of human Pex14 binds Pex19 in addition to Pex5 ([@bib232]). Interestingly, an F/YFxxxF motif in the N terminus of Pex19 associates with the same site in Pex14 as the Pex5 WxxxF/Y motif. Although the key role of [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) is in sorting of PMPs (see below), in this case it possibly plays a role in the assembly of the docking complex ([@bib93]).

Although it is generally accepted that [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) is the initial [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) receptor in the peroxisomal membrane, the molecular mechanisms involved in its function are still unknown. Moreover, *H. polymorpha* Pex14 has additional functions, for example, in peroxisome degradation by autophagy ([@bib28]; [@bib383]). Interestingly, data in *H. polymorpha* also indicate that PTS1 protein import can proceed in a *PEX14* deletion strain upon overexpression of Pex5 ([@bib280]). This suggests that [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) is not essential but rather important for the efficacy of matrix import and that [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) also takes part in the protein translocation process.

### RING finger complex: {#s37}

The "*r*eally *i*nteresting *n*ew *g*ene" (RING) complex involved in peroxisome biogenesis and function consists of three proteins---[Pex2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003746), [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673), and [Pex12](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004628)---that interact with each other. They contain RING domains at their cytosolic C termini, which bind zinc ions through characteristic conserved cysteine and histidine residues. As these proteins are integral membrane proteins, it was proposed that they form the actual translocation pore through the membrane. Recent findings, however, indicate that these proteins have E3 ubiquitin ligase activity and function together with the ubiquitin-conjugating E2 enzymes [Pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365) or [Ubc4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000286). Indeed, [Pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365) plays an important role in matrix protein import ([@bib356]), whereas [Ubc4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000286) is not required for this process. Instead, [Ubc4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000286) is responsible for a quality control mechanism that results in degradation of nonfunctional [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) molecules by polyubiquitination and their subsequent degradation by the proteasome ([Figure 6A](#fig6){ref-type="fig"}) ([@bib162]).

[@bib359] were the first to show that the RING domain of [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673) exhibits E3 ligase activity and acts as E3 ligase for [Ubc4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000286)-dependent polyubiquitination of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652). [@bib260] subsequently demonstrated that all three RING finger peroxins exhibit ubiquitin-ligase activity. These authors, however, reported that [Pex2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003746), but not [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673), is essential for [Ubc4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000286)-dependent polyubiquitination, whereas [Pex12](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004628) catalyzes [Pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365)-dependent monoubiquitination of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652). Monoubiquitination is important for recycling of functional [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) molecules to the cytosol to mediate another round of PTS1 protein import ([Figure 6A](#fig6){ref-type="fig"}). *[pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673)* mutants show a severe defect in matrix protein import, which could be due to the stabilizing function of [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673) on the other RING finger proteins. However, as [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673) also has E3 ligase activity, the important current question concerns what the substrate of [Pex10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002673) actually is.

### Translocation pore: {#s38}

The general view on the peroxisomal translocon is that it is composed of two subcomplexes, the receptor docking complex and the RING finger complex, which are organized into the so-called importomer by [Pex8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003309) ([@bib5]). Studies in *H. polymorpha* indicated that Pex8 is also required for cargo release from Pex5 ([@bib354]), indicating a dual role for Pex8. A recent proteomics study confirmed the presence of proteins of the docking complex and the RING finger complex, together with [Pex8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003309), in the core complex of the peroxisomal translocon. In addition, [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) and [Dyn2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002832), the microtubule motor protein, also were observed to be closely associated with the peroxisomal core translocon ([@bib237]).

In *Pichia pastoris* [@bib132] proposed that [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737), rather than [Pex8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003309), is the protein that sequesters both subcomplexes into the translocon. However, this protein was identified as a component of neither the 9 core nor the 12 transient components of the importomer in *S. cerevisiae* ([@bib237]). Rather, [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) is a peroxin that is implicated in peroxisomal membrane biogenesis (see below).

The actual mode of matrix protein import is still elusive. Recently, the group of Erdmann ([@bib216]) provided evidence for the concept of a transient pore, composed of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) and [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) oligomers. This transiently gated ion-conducting channel may form pores of variable sizes up to 9 nm, which are induced by the interaction with the receptor cargo complex. This model also explains that the peroxisomal translocon pore may accommodate 9-nm gold particles ([@bib351]). The occurrence of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) oligomers would be in line with electron microscopy data obtained from isolated *H. polymorpha* Pex5 ([@bib218]). On the other hand, by using small-angle X-ray scattering, [@bib298] suggested that human [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) is rather monomeric in solution. Nevertheless, the option of a transient pore consisting of [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) and [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) oligomers to mediate matrix protein import is quite attractive. As it stands now, however, this model still leaves many questions open, *i.e.*, how the import process is regulated and how the translocon is able to accommodate large receptor-bound oligomeric matrix proteins.

### Receptor recycling and the role of ubiquitin: {#s39}

The final step in PTS1 matrix protein import is the recycling of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) to the cytosol. The first indication that [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) is indeed a cycling receptor came from the observation that in wild-type *H. polymorpha* Pex5 shows a dual localization in the cytosol and the peroxisomal matrix ([@bib338]). Subsequent studies in the same organism indicated that the absence of Pex4 resulted in a specific block in PTS1-protein import that could be suppressed by overexpression of *PEX5*. Whereas in wild-type cells overproduced [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) was localized mainly to the cytosol, it accumulated in *[pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365)* cells at the inner surface of the peroxisomal membrane. This observation led to the proposal that [Pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365), and hence ubiquitination, is involved in receptor recycling ([@bib339]). Erdmann's group has significantly contributed to unraveling the principles of the [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) recycling process (for a review see [@bib292]). In the normal receptor recycling process, [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) is mono-ubiquinated at a conserved cysteine by [Pex4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003365) and [Pex12](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004628). Poly-ubiquitination of [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) occurs on a lysine residue ([@bib161]). Release of the receptor from the membrane is an ATP-dependent process that is facilitated by the two AAA ATPases, [Pex1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680) and [Pex6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005273), which are recruited to the membrane by [Pex15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005404). [@bib66] recently identified a novel component, [Ubp15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004920), which is capable of removing ubiquitin from [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652). Although the model of a cycling [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) receptor is today generally accepted, it is still debated whether in yeast [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) associates to the outer surface of the membrane, inserts into the membrane, or even transiently enters the peroxisomal membrane, as suggested by the data obtained in *H. polymorpha*. The current knowledge of protein import and receptor recycling is summarized in [Figure 6A](#fig6){ref-type="fig"}.

On this point only the PTS1 peroxisomal protein import pathway has been studied in greater detail, but evidence suggests that the PTS2 receptor [Pex7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002549) may also cycle and enter the matrix, based on the observed localization of this protein in the peroxisomal matrix (for a review see [@bib191]) ([Figure 6B](#fig6){ref-type="fig"}).

Sorting and insertion of PMPs {#s40}
-----------------------------

Like matrix proteins, PMPs are synthesized in the cytosol. However, whether they immediately insert into the peroxisomal membrane or traffic first to the ER is currently still strongly debated. PMP-targeting signals (mPTSs) may involve different regions of the PMPs and are not characterized by a simple consensus sequence. Two classes of PMPs have been defined: class I PMPs contain an mPTS that is recognized by the soluble farnesylated protein Pex19. Class II PMPs, such as Pex3, Pex16, and Pex22, contain membrane-targeting information that is not recognized by Pex19 ([@bib151]). The prevailing model for class I PMPs sorting suggests that cytosolic Pex19 serves as a cycling mPTS receptor, which docks to Pex3 on the peroxisomal surface, after which the cargo PMP is inserted into the membrane via a still-unknown pathway (reviewed in [@bib290]). In line with this model is the observation that Pex19 binds mPTSs that are required for targeting ([@bib151]). Recently, the crystal structure of the C-terminal part of human Pex19 was solved, which revealed that mPTSs bind to a globular α-helical domain in the C terminus of the protein ([@bib294]). However, there are conflicting data on the exact role of [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) in the biogenesis of the peroxisomal membrane. For example, in *H. polymorpha* and *S. cerevisiae*, *[pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* mutant cells that overproduce [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) peroxisomal membrane structures that contain PMPs exist, suggesting that [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) is not essential for the insertion of PMPs into peroxisomal membranes ([@bib245]). Similarly, in *Y. lipolytica* cells lacking [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) structures are present that resemble normal peroxisomes even without [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) overproduction ([@bib188]). On the basis of these and other observations it has been suggested that [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) is required mainly to assemble PMP complexes at the peroxisomal membrane and, hence, may function as a chaperone instead of being an mPTS receptor protein.

Data by [@bib340] suggest, on the basis of live-cell imaging experiments, that in *S. cerevisiae* all PMPs travel via the ER to peroxisomes. The authors propose novel functions for [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) and [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) in the budding of peroxisomal vesicles from the ER. According to these studies, insertion of PMPs into the ER depends on the [Sec61](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004370) translocon, except for the tail-anchored protein [Pex15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005404), which requires [Get3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002258). Notably, in previous studies by [@bib305] no effect of the inactivation of [Sec61](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004370) on peroxisome formation could be demonstrated.

The process of budding of PMP-containing vesicles from the ER proposed by [@bib340] is supported by data generated by [@bib187], who used a cell-free *in vitro* vesicle-budding assay. Using this assay, *S. cerevisiae* [Pex15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005404) and [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) were shown to be packaged into small vesicles that derived from the ER in a process that was dependent on [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223). These vesicles were formed by a novel budding mechanism and independently of the COPII machinery that is responsible for secretory cargo packaging at the ER. Possibly, these vesicles fuse homotypically to create a new peroxisome, the so-called *de novo* peroxisome formation process (see below), or they fuse with preexisting peroxisomes as a mode to transfer PMPs and lipids from the ER to these organelles. In a similar study using permeabilized *P. pastoris* cells, [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) and [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) were shown to be copackaged into ER-derived vesicles in a [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)-dependent process ([@bib6]). Interestingly, this study revealed that the vesicles were also formed in the absence of [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737), suggesting that this peroxin is not essential for vesicle formation. This finding also implies that [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) can dock to the ER membrane without its presumed membrane docking protein [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737). Notably, this observation is in line with earlier data, which indicate that, in *P. pastoris [pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* mutant cells, small structures that contain PMPs are present ([@bib132]).

Although the above studies indicate that some PMPs initially may insert into the ER membrane, data have been reported that indicate that targeting of several PMPs (including [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)) to the ER is rather inefficient, especially when endogenous promoters are used to drive gene expression of the reporter constructs. For example, a fusion protein of full-length [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) and GFP, expressed under control of the *[PEX3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* promoter in *H. polymorpha pex19* cells, localizes to the cytosol ([@bib245]). Similarly, tagged [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) produced under control of the endogenous promoter is localized to the cytosol in *S. cerevisiae [pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* and *[pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* mutant strains ([@bib136]). Also, in *H. polymorpha pex11 pex25* double-mutant cells, which are fully devoid of peroxisomal membrane structures, [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)-GPF produced under control of the endogenous *[PEX3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* promoter is cytosolic ([@bib284]).

Although in most studies PMPs were shown to colocalize with ER markers even when expressed at wild-type levels, the kinetics of their production (*e.g.*, pulsed induction of GFP-tagged proteins using strong inducible promoters) may be quite different from the wild-type situation. Hence, it cannot be excluded that deregulated expression contributes to enhanced targeting of these proteins to the ER. The apparently contradictory data on PMP sorting may also depend on the model and reporter proteins used. This may be concluded from data of the Fujiki laboratory ([@bib212]), who demonstrated that in mammals Pex3 is directly sorted to peroxisomes. For this sorting, [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) serves as a chaperone for full-length [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) to form a soluble complex in the cytosol, which docks to Pex16 at the peroxisomal membrane.

A number of PMPs in various cell types show a dual localization to the ER and peroxisomes under steady-state conditions, for example, plant Pex16 ([@bib160]), *P. pastoris* [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316) and [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236) ([@bib366]), and *S. cerevisiae* [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507). In the case of *S. cerevisiae* [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507), the localization varies with the phosphorylation state of the protein ([@bib168]). Whether these ER-localized proteins are on their way to peroxisomes is, however, not firmly established. The key questions to date are whether in wild-type cells all or a subset of the PMPs travel via the ER to peroxisomes under normal physiological conditions and whether the vesicles formed in the *in vitro* assays represent transport vesicles or preperoxisomes of a *de novo* synthesis pathway. The current availability of *in vitro* assays will significantly help in further understanding these important questions in PMP sorting.

Formation of peroxisomes from the ER {#s41}
------------------------------------

Several observations based on electron microscopy have suggested that new peroxisomes can be formed from the ER. Membrane connections appear to exist between peroxisomes and the ER in mouse dendritic cells, allowing new peroxisomes to pinch off from specialized regions of the ER ([@bib103]). Also, evidence obtained in yeast *[pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* and *[pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* mutants that lack peroxisomal membrane structures suggests that peroxisomes can be formed from the ER upon reintroduction of the corresponding *[PEX3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* or *[PEX19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223)* wild-type genes ([@bib139]; [@bib177]; [@bib321]; [@bib122]). *In vivo* pulse-chase experiments using [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)-GFP in *S. cerevisiae [pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* cells ([@bib139]) revealed that [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)-GFP is first targeted to the ER, but later present in new, small peroxisomes. Very similar observations have been made in other laboratories using *S. cerevisiae* and in *H. polymorpha* (for a review see [@bib318]).

An alternative explanation for the ER-localized [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) in these experiments, however, may be that peroxisomes are formed by an alternative, relatively slow process, thus promoting excess [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) to sort to the ER, when insufficient peroxisomal membrane is present. Likely, [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) and other PMPs may contain ER-targeting signals, but these are not yet resolved. Therefore, during *de novo* synthesis, these proteins, including [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737), may initially sort to the ER but later on be targeted directly from the cytosol to the newly formed organelle without a requirement for translocation via the ER. In line with this suggestion is the general observation that these PMPs are never observed at the ER in wild-type cells grown under normal conditions. However, this could also be explained by an extremely short residence time of these proteins at the ER.

A role for the ER in peroxisome biogenesis is also indicated by observations of [@bib256], who showed that [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)-GFP localizes to tubular-vesicular structures in cells suppressed for [Sec20](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002906), [Sec39](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004432), and [Dsl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005202), which form a complex in the ER. Also, deletion of *[ARF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002351)* and *[ARF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005620)* in *S. cerevisiae* affects peroxisome proliferation ([@bib13]). However, details on the exact function of these proteins in peroxisome biogenesis are still lacking.

Several attempts have been made to identify genes that are essential for the *de novo* peroxisome formation process. In *H. polymorpha*, several gene deletions have been tested for their effect on the reintroduction of peroxisomes in *pex3* mutant cells upon induction of Pex3-GFP synthesis. These studies revealed that Dnm1, Vps1, Emp24, Pex11, and Pex11C are not required ([@bib228]; [@bib186]; [@bib284]). However, [@bib284] showed that Pex25 as well as the GTPase Rho1 are necessary to allow the formation of new peroxisomes in *[pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)* cells. [@bib144] showed that in *S. cerevisiae* [Pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033) also is essential for reintroduction of peroxisomes in [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737)-deficient cells. Since *H. polymorpha pex25* and *S. cerevisiae [pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033)* cells contain normal peroxisomes, the above process apparently is not essential in wild-type cells to maintain peroxisomes.

Recent findings by [@bib341] suggest that in *S. cerevisiae* the process of peroxisome formation from the ER involves at least two biochemically distinct types of preperoxisomal vesicles that are initially formed from the ER, which each carry half a peroxisomal translocon complex and hence are unable to import peroxisomal matrix proteins. Upon their fusion, mediated by the AAA proteins [Pex1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680) and [Pex6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005273), a functional translocon is formed allowing uptake of peroxisomal matrix proteins from the cytosol. This model suggests a novel role for [Pex1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680) and [Pex6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005273) in vesicle fusion, in addition to their established function in [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) recycling. Notably, earlier data obtained in the yeast *Y. lipolytica* also suggested the formation of mature peroxisomes upon fusion of different subtypes of small preperoxisomal vesicles ([@bib329]). Fusion of various types of vesicles was mediated by [Pex1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001680) and [Pex6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005273); however, the origin of the vesicles remains unknown. All vesicles were matrix protein import competent, although the vesicle subtypes contained different combinations of peroxisomal proteins.

In summary, peroxisome formation can occur *de novo* in cells lacking pre-existing peroxisomes. However, the significance of *de novo* peroxisome formation in cells that already have peroxisomes is still debated.

Peroxisome fission {#s42}
------------------

### Pex11 and the Fis1/Dnm1 fission machinery: {#s43}

For decades, peroxisomes have been considered to be autonomous organelles that multiply by growth and division ([@bib193]). Various proteins are known to function in peroxisome fission. The first step in fission is organelle elongation, a process that is mediated by [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) ([@bib243]). In all studies performed in various species so far artificial modulation of [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) levels has resulted in variations in peroxisome size and abundance; deletion of the *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)* gene invariably leads to fewer enlarged organelles, whereas *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)* overexpression leads to an increased number of smaller and often tubulated peroxisomes. Studies in *H. polymorpha* ([@bib243]) revealed that the insertion of the N-terminal amphipathic α-helix of [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) into the membrane causes the initial membrane curvature, which initiates organelle elongation. The activation of [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) in organelle fission may be regulated by phosphorylation/dephosphorylation ([@bib278]; [@bib168]). Mutant studies indicate that strains producing constitutively dephosphorylated [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) show a phenotype similar to *[pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)* cells, whereas strains expressing a phosphomimetic [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) mutant allele show enhanced peroxisome proliferation, similar to cells overexpressing *[PEX11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)*.

Recent observations indicate that in the yeasts *S. cerevisiae* and *H. polymorpha* most of the organelles are formed by fission of existing peroxisomes by the activity of the *d*ynamin-*r*elated *p*roteins (DRP) [Dnm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924) and [Vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709) ([@bib138]; [@bib219]; [@bib228]). This is, among other observations, suggested by the finding that, in cells of a *[dnm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924)[vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709)* double-deletion strain, peroxisome fission is completely blocked, resulting in the presence of a single enlarged peroxisome per cell, even after prolonged cultivation under peroxisome-inducing conditions. In these cells, peroxisome formation from the ER is not affected, but generation of additional organelles was never observed ([@bib219]; [@bib228]).

DRPs are large GTPases that are involved in multiple membrane fission and fusion events. [Vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709) was initially found to be involved in vacuolar protein sorting, whereas [Dnm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924) was first identified as a protein required for mitochondrial fission. The peroxisomal fission machinery is therefore not unique for this organelle, but shares components with other membrane fission/fusion processes. [Dnm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924) is essential for peroxisome fission under conditions of peroxisome induction by oleate, whereas [Vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709) functions under glucose-repressing conditions ([@bib138]; [@bib185]). In *S. cerevisiae*, [Dnm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003924) is recruited to peroxisomes by [Mdv1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003648) or its paralog [Caf4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001744), which are both associated with the peroxisomal membrane via the tail-anchored protein [Fis1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001327) ([@bib219]; [@bib220]). [Mdv1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003648) and [Caf4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001744) are WD repeat proteins, which are absent in higher eukaryotes. How [Vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709) is recruited to peroxisomes is not yet known. Notably, in *H. polymorpha*, Vps1 does not play a role in peroxisome fission, and, thus, this yeast species seems to be more similar to higher eukaryotes in this respect, in which a single DRP is involved in mitochondrial and peroxisome fission, as well as in chloroplast fission, in plants.

It is an intriguing question how the [Fis1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001327)/Drp fission machinery is properly distributed over the individual organelles. In higher eukaryotes, [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) has been implicated in the recruitment of [Fis1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001327) to peroxisomes ([@bib169]; [@bib199]); in mammals, a role of [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) in [Fis1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001327) targeting was established ([@bib68]), but these processes have not yet been confirmed in yeast. Fluorescence microscopy studies in *H. polymorpha* revealed that GFP-tagged Dnm1 is not evenly distributed in the cell, but rather present in multiple spots to which Mdv1 colocalizes. These spots dynamically associate and disassociate from mitochondria and peroxisomes, demonstrating that the same protein molecules may be involved in the fission of either one of these organelles ([@bib227]).

Peroxisome fission in *H. polymorpha* is fully blocked in *dnm1* cells. Growing *H. polymorpha dnm1* mutant cells contain a single enlarged peroxisome, which forms a long extension that protrudes into the developing bud. These extensions are not observed in *dnm1 pex11* cells, which is in agreement with the notion that Pex11 plays a role in peroxisome elongation ([@bib228]). Remarkably, Pex11 protein concentrates at the base of these peroxisome extensions, indicating that during fission of the organelles Pex11 segregates into Pex11-enriched patches at the membrane. Recent findings show that other peroxins including Pex10, Pex14, but also the Pex11-family protein Pex25, do not segregate to the same patches; instead, these proteins move to the developing new organelles or extensions in *dnm1* cells ([@bib52]).

### Role of the other Pex11 protein family members: {#s44}

Most organisms contain at least three [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) protein family members (see [Table 2](#t2){ref-type="table"}). The human genome encodes three family members, namely Pex11α, Pex11β, and Pex11γ, all of which have high similarity to *S. cerevisiae* [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507). *S. cerevisiae* expresses, in addition to [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507), the weakly homologous [Pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033) protein and its partially redundant paralogue, [Pex27](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005719) ([@bib276]), which have also been implicated in peroxisome proliferation. Quantitative analysis of electron microscopy images revealed that peroxisomes are enlarged in *[pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507)*, *[pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033)*, or *[pex27](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005719)* mutant cells ([@bib320]). The molecular function of [Pex27](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005719) is still unclear, whereas [Pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033) plays a role in recruiting [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369) to the peroxisomal membrane ([@bib205]). In *H. polymorpha*, Pex25, but not Pex11 or Pex11c, has been shown to be important for the formation of peroxisomes from the ER ([@bib284]). Large-scale protein interaction studies by two-hybrid analysis ([@bib371]), together with information from a global analysis of protein localization ([@bib145]), led to the identification of a novel peroxisomal interaction partner of [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507), [Pex25](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006033), and [Pex27](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005719), named [Pex34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000561); [Pex34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000561) was proposed to act as a positive effector of peroxisome division ([@bib331]).

### Pex23 protein family: {#s45}

Based on sequence homology, [@bib163] defined the Pex23 protein family, which contains the membrane proteins Pex23, Pex24, [Pex28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193), [Pex29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887), [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372). This family of peroxisomal proteins can be divided into two groups of proteins with weak similarity (see [Table 2](#t2){ref-type="table"}; [@bib163]): The first group consists of *Y. lipolytica* Pex23 ([@bib45]) and the related *S. cerevisiae* proteins [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372) ([@bib347]) and *P. pastoris* [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316) and [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236) ([@bib366]). These proteins contain a DysF motif with an unknown function that was first observed in human dysferlin. The second group contains *Y. lipolytica* Pex24 ([@bib319]) and *S. cerevisiae* [Pex28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193) and [Pex29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887) ([@bib346]).

*Y. lipolytica* Pex23 is an integral peroxisomal membrane protein. *S. cerevisiae* [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372) are localized to peroxisomes; however, a significant portion of [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316) is present in lighter fractions in sucrose gradients. These fractions may represent the ER, as *P. pastoris* [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316) and [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236) show a dual localization to the ER and peroxisomes. In *Y. lipolytica pex23* mutant cells, the majority of the peroxisomal matrix proteins is mislocalized to the cytosol, but the cells still contain small vesicular structures that contain PTS1 and PTS2 proteins. The phenotypes of *S. cerevisiae [pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316)*, *[pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236)*, and *[pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372)* cells are quite different because they contain peroxisomes in which matrix proteins are normally imported. In *[pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316)* mutant cells, the number of peroxisomes is increased, and [*pex31*](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236) and *[pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372)* cells have enlarged peroxisomes. It was proposed that, in *S. cerevisiae*, [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316) is a negative regulator of peroxisome number, whereas [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236) and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372) are negative regulators of peroxisome size ([@bib347]). Notably, in *P. pastoris*, deletion of *[PEX30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316)* or *[PEX31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236)* results in the opposite effect, namely a reduction in peroxisome number ([@bib366]).

*Y. lipolytica PEX24* encodes for a peroxisomal membrane protein, and *PEX24*-deficient mutants lack morphologically recognizable peroxisomes, but instead contain unusual extended membrane structures ([@bib319]). Immunofluorescence microscopy suggested a cytosolic localization for PMPs and matrix proteins in these mutants; however, using biochemical approaches, membrane fractions could be detected that contained minor amounts of matrix marker proteins. Hence, *pex24* mutant cells apparently fail to assemble functional peroxisomes, but still contain membrane structures that exhibit some peroxisomal characteristics.

In *S. cerevisiae* cells in which either one or both *[PEX28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193)* and/or *[PEX29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887)* are deleted, peroxisome assembly is not affected. These mutant cells contain organelles that have a lower density, are smaller, are more abundant, and tend to cluster ([@bib346]). Two-hybrid studies revealed that [Pex28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193) and [Pex29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887) interact with [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372). Systematic deletion of genes demonstrated that *[PEX28](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001193)* and *[PEX29](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002887)* function upstream of [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), [Pex31](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003236), and [Pex32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000372) and function together with these proteins in the regulation of peroxisome proliferation ([@bib347]).

In summary, the *Y. lipolytica* members of the Pex23 family seem to play a key role in peroxisome assembly, whereas the *S. cerevisiae* and *P. pastoris* members are important in the regulation of peroxisome proliferation. Detailed knowledge about the function of these proteins is required to understand the major species-specific differences in the phenotypes of the respective deletion strains.

Peroxisome inheritance {#s46}
----------------------

During budding of yeast cells, one or a few organelles are actively transported to the developing bud, a process that is mediated by the class V myosin motor protein [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) and [actin](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855) filaments ([@bib138]). The remaining peroxisomes are retained in the mother cell. [Inp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004817) has been identified as the peroxisome-specific retention factor, connecting peroxisomes to an as-yet-unknown anchoring structure in the mother cell. The Hettema laboratory demonstrated that [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) recruits [Inp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004817) to the peroxisomal membrane ([@bib224]). Importantly, the [Inp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004817)-binding region in the [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) protein is distinct from the regions involved in membrane formation. Unexpectedly, in the absence of [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507), peroxisome retention is also defective in *H. polymorpha*, despite the fact that [Inp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004817) is properly localized to peroxisomes ([@bib179]). Hence, [Pex11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005507) appears to have a second function in organelle retention, in addition to its role in peroxisome fission.

[Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773) is a PMP that acts as the peroxisomal receptor for [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) and attaches the globular tail of [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) to the peroxisome, thus allowing transport of the organelle to the bud. The region of [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) involved in [Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773) binding was identified using mutant variants of [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853). These studies also showed that [Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773) is a phosphoprotein whose level of phosphorylation is coupled to the cell cycle ([@bib83]; [@bib84]). Recently, [@bib248] provided evidence that [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) also plays a role in peroxisome inheritance by associating peroxisomes to [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853). Interestingly, mutations that affect the interaction between [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) and [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223) do not abolish the [Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773)--[Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853) interaction.

[@bib53] suggested that [Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773) is unique for *S. cerevisiae* and related species because in *Y. lipolytica* Pex3 and its paralog Pex3B function as peroxisome-specific receptors of [Myo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005853). However, [Inp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004773) is also present in other yeast species. The finding that *H. polymorpha* Inp2 interacts with Myo2 points to a conserved function of Inp2 as a binding protein for Myo2 ([@bib283]). Remarkably, in *H. polymorpha*, Myo2--Inp2 binding was dependent on Pex19. This is consistent with the view that Pex19 may have a stabilizing role in the interaction between Inp2 and Myo2 and is also in line with the previously observed defect in peroxisome inheritance in *H. polymorpha pex19* cells ([@bib247]).

Peroxisome degradation {#s47}
----------------------

The actual peroxisome population per cell is largely prescribed by physiological needs and determined by the machineries of organelle proliferation, inheritance, and degradation. Peroxisome inactivation can be achieved by degradation of (part of) their constituents or by turnover of the whole organelle by autophagy ([@bib384]). Organelle degradation by autophagy can serve three main cellular functions, namely nonselective degradation, *e.g.*, under nutrient depletion conditions to recycle cellular material; selective degradation of redundant organelles; and constitutive degradation to remove exhausted organelles as a mode to continuously rejuvenate the organelle population ([@bib7]). Selective peroxisome degradation is also designated as "pexophagy" ([@bib166]). Two distinct mechanisms of pexophagy, termed "macropexophagy" and "micropexophagy," which can be morphologically distinguished, may occur. During macropexophagy, individual organelles are sequestered by a double-membrane structure, the autophagosome, which fuses with the vacuole and releases the organelle into the lytic environment of the vacuole. During micropexophagy an organelle or a cluster of organelles is engulfed by vacuolar extensions, followed by incorporation of the organelle into the vacuole.

Most studies of the molecular mechanisms involved in pexophagy have been performed with methylotrophic yeast species such as *H. polymorpha* or *P. pastoris*. When these organisms are grown on methanol, peroxisomes are massively induced. However, upon transfer of methanol-grown cells to glucose media, these organelles become redundant for growth and are therefore rapidly degraded by pexophagy. Pexophagy involves a core set of *ATG* genes that also plays a role in other autophagy processes ([@bib215]). In addition, a few genes that are specifically involved in pexophagy are known (for recent reviews see [@bib277] and [@bib204]). Although homologous genes exist in *S. cerevisiae*, their specific roles in pexophagy in this organism have not been elucidated yet.

Peroxisome function and biology in yeast as a paradigm for metabolic disorders in humans {#s48}
----------------------------------------------------------------------------------------

Yeast is a very useful model ("reference organism") to understand basic processes of peroxisome biology in humans. As in yeast, human peroxisomes harbor enzymes of the β-oxidation pathway. However, in addition, they are involved in other processes that do not occur in *S. cerevisiae*, such as ether phospholipid biosynthesis, fatty acid α-oxidation, and the oxidation of *D*-amino acids and of polyamines (for reviews see [@bib352] and [@bib353]). Also, unlike in yeast, mammalian peroxisomal β-oxidation is restricted to very long chain fatty acids (VLCFAs); short- and medium-chain FAs are oxidized by mitochondrial enzymes in mammals, whereas mitochondrial β-oxidation does not exist in *S. cerevisiae*, and short-, medium-, and long-chain fatty acids are solely degraded in peroxisomes in that organism. Since the metabolic pathways in yeast and human peroxisomes are quite distinct, yeast research has only poorly contributed to the understanding of the metabolism of human peroxisomes. In marked contrast, however, studies of yeast peroxisome biogenesis have been instrumental in identifying human counterparts of yeast peroxins and in understanding the molecular basis of peroxisome biogenesis disorders (PBDs). In PBD patients, normal peroxisomal structures are absent, causing dramatic defects in peroxisomal metabolism. Among other deficiencies, PBDs lead to the accumulation of very long chain fatty acids or defective plasmalogen synthesis, and PBD patients develop liver diseases, variable neurodevelopmental delay, retinopathy, and perceptive deafness with onset in the first months of life. The most severe PBD is Zellweger syndrome, and patients suffering from this disease typically die before one year of age ([@bib312]).

In 1973 [@bib108] described that cells of Zellweger syndrome patients were fully devoid of peroxisomal structures. However, it was not until 1992 that the first gene associated with a peroxisome biogenesis disorder was identified by complementation of fibroblasts isolated from a patient with Zellweger syndrome ([@bib297]). In later studies, the cloning and sequencing of yeast *PEX* genes has greatly facilitated the identification of the corresponding human genes by homology probing and searches in human genome databases. The genes that have been shown to be defective in PBDs are so far limited to those that play a role in matrix protein import and in the formation of the peroxisomal membrane, *i.e.*, [Pex3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002737) and [Pex19](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002223). In addition, Pex16 is required for membrane biogenesis in humans. However, several of the other *PEX* genes appear to be yeast specific and do not have a clearly defined structural ortholog in humans (for a review see [@bib312]).

Most of the research on yeast peroxisomes is performed using *S. cerevisiae* due to the extensive set of experimental tools that was first available for this species; however, other yeast species have specific advantages for peroxisome research, as their peroxisomes are more similar to their human counterparts in certain aspects. This has become apparent from the presence of orthologs of typical human peroxisomal enzymes in several yeast species, such as *D*-amino acid oxidases and polyamine oxidases, which are absent from *S. cerevisiae*. As outlined above, this is also true for peroxisomal processes, such as organelle fission. All eukaryotes, with the exception of *S. cerevisiae*, contain a peroxisomal Lon protease ([@bib7]), and studies in *H. polymorpha* and *Penicillium chysogenum* revealed that this protease is very important for quality control processes in the organelle ([@bib7]; [@bib27]). Hence, studies on peroxisome biology in other fungi may have specific advantages over *S. cerevisiae* in understanding peroxisome-related processes in humans.

Outlook and perspectives {#s49}
------------------------

For many years the peroxisome field has struggled, and in fact still struggles, with major controversies regarding the mode of peroxisome biogenesis and development. One topic currently under heavy debate are the mechanisms by which peroxisomes are formed. Data in several yeast species indicate that, following their induction, peroxisomes predominantly proliferate by fission, whereas other data suggest that all organelles are derived from the ER, as suggested for mammalian peroxisomes. Potentially, ER-derived peroxisomes are capable of one or only a few fission events. Clearly, this point needs urgent elucidation and requires the identification and analysis of novel components that are essential for this process. Similarly, novel approaches will help to resolve the question of how the various PMPs reach the peroxisome membrane. It is attractive to suggest that sorting of at least some PMPs may be associated with lipid transfer from the ER, since the organelles increase in size during maturation; on the other hand, PMP and lipid import may also be separate processes. Notably, a major constituent of the peroxisomal membrane is cardiolipin, which is synthesized in the inner mitochondrial membrane, adding another level of complexity to the peroxisome assembly process.

The question of how matrix proteins enter peroxisomes has long been enigmatic but seems now to be have been cracked by the observations of the Erdmann group that these proteins enter via a transient pore, formed by [Pex5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002652) and [Pex14](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003121) molecules ([@bib216]). However, many questions remain, for example, regarding the composition and regulation of this pore. Particularly interesting is the excellent suggestion by [@bib111] who proposed that receptor and matrix proteins may form large complexes (pre-import complex) prior to the membrane translocation step. An estimated pore diameter of up to 90 Å would indeed allow the import of such complexes. The formation of such complexes at the organelle membrane may also explain why the pool of matrix precursor proteins in the cytosol is invariably extremely low. In the end, detailed protein structure information will be required to end the debate over the function of this fascinating and unique protein translocation machinery.

For the identification of novel peroxisome components, transcriptome studies have been proven to be of low value. Also, *in silico* prediction methods need improved programs. A major limitation in proteomics studies to identify novel components of the peroxisomal import and assembly machinery is the insufficient purity of the organelle fractions that are obtained by currently available fractionation protocols. Moreover, because of the occurrence of dual localizations of proteins, *e.g.*, of [Fis1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001327) and [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369), which are dually localized to mitochondria and peroxisomes, or [Pex30](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004316), which is present in peroxisomes and the ER, certain proteins can erroneously be regarded as contaminants. Also, current procedures to isolate peroxisomal fractions are time-consuming and involve many purification steps, which may result in the dissociation of proteins that only weakly or transiently interact with the peroxisomal surface. Moreover, it is difficult to isolate intact organelles, and leakage of matrix proteins during the isolation procedure is invariably observed. An additional potential drawback may be the use of density centrifugation in current protocols since only organelles of high density are isolated; several data, however, indicate the presence of organelle subpopulations ([@bib345]), and immature developing organelles that do not cofractionate with the dense mature organelle fractions exist. In fact, the lighter, nascent organelles may carry the bulk of proteins important for peroxisome biogenesis and dynamics ([@bib79]; [@bib52]) and therefore are missed in the current isolation procedures. Procedures that are independent of peroxisome size or density would help in isolating the whole peroxisome population of cells. Immunopurification and FACS-based methods have been attempted, but need further improvement.

In general, the importance of peroxisomes has long been greatly underestimated. We anticipate that due to the technical drawbacks in identifying all relevant peroxisomal components the atlas of peroxisome functions is still far from being complete. This assumption is supported by the recent identification of several novel crucial functions, *i.e.*, non-metabolic activities that are required to cope with stress conditions other than oxidative stress, especially in plants. Among these are roles in reactive nitrogen species signaling, aging, antiviral innate immunity, and plant defense against pathogens ([@bib75]; [@bib192]). Of particular interest also are data indicating that peroxisomes play a role in aging in various species, including humans ([@bib8]; [@bib34]; [@bib327]). It is therefore important to analyze cells that have been grown under various conditions, including stress scenarios, to identify novel potential peroxisome functions in stress and aging.

Despite technical limitations, peroxisomes are among the best-characterized organelles in terms of composition, biogenesis, inheritance, and turnover in yeast. The field of lipid droplet research, on the other hand, is still in its infancy, despite the important role of this organelle in lipid homeostasis and its implication in prevalent metabolic diseases in mammals. Only models of how the neutral lipid of the LD core is formed exist, and although increasing evidence suggests a close functional interaction of LDs and the ER, the specific molecular mechanisms of LD formation are obscure ([@bib87]; [@bib349], [@bib350]). As discussed above for peroxisomes, the biochemical characterization of LD composition is limited since current LD isolation methods based on cell fractionation are time-consuming and may lead to cross-contamination with other cellular compartments or to loss of transiently associated components. Since LDs are typically isolated by flotation due to the low density of the TAG and SE core components, nascent LDs that contain less TAG and SE cannot be isolated by that method. As a consequence, the "time window" for LD isolation during cell cultivation is rather narrow and limited to the late-log/early stationary phase of growth. Thus, in addition to the mechanisms that drive LD formation, such fundamental concerns as determining the mechanism of protein targeting to LDs are largely unresolved. Anabolic LD enzymes are frequently also associated with the ER, whereas catabolic LD enzymes are exclusively LD resident: Which signals regulate the distribution of proteins between the ER and LDs? How are ER-resident proteins excluded from LDs? Evidence suggests that hydrophobic stretches of amino acids are required to drive LD association, but the topology of these potential transmembrane domains in the monolayer leaflet of the LD surface remains obscure. Since LDs may also serve as an overflow compartment for (misfolded) hydrophobic proteins, experimental use of episomally expressed fusion constructs to investigate targeting sequences may be misleading. Wild-type cells are characterized by a remarkably homogeneous size distribution of LDs ([@bib63]). What limits the size of LDs? Do LDs fuse *in vivo*? Are there specific subpopulations of LDs, harboring either SEs or TAGs, and are there also differences in the protein content between LDs? Yeast provides the unique opportunity to deplete LDs and induce their formation by regulated expression of acyltransferases that drive TAG synthesis ([@bib148]), thus enabling studies on the early events of LD biogenesis and their interaction with the ER. Further refinement of isolation procedures and proteomic and lipidomic analysis will provide better insight into composition under various nutritional conditions ([@bib59]; [@bib114]). The exploitation of components involved in the physical interaction between LDs and mitochondria or peroxisomes ([@bib264]) may also contribute to a better understanding of the interconnection between lipid storage and cellular physiology. In conclusion: many challenges remain and are open to further exploration of the biology of these fascinating organelles, the peroxisome and lipid droplets.
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The numbers indicate the total number of carbon atoms in the acyl chains and the number of double bonds. Yeast produces only mono-unsaturated FAs; thus TAG 52:3 indicates a species containing C18:1 + C18:1 + C16:1 acyl chains.

In the original publication, TAG levels were erroneously printed as "mg TAG/mg cell dry weight" (K. Athenstaedt, personal communication)
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